Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
TISSUE DEVELOPMENT |
467 |
1518 |
2.914e-49 |
1.356e-45 |
2 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
288 |
788 |
1.574e-45 |
2.441e-42 |
3 |
CIRCULATORY SYSTEM DEVELOPMENT |
288 |
788 |
1.574e-45 |
2.441e-42 |
4 |
NEUROGENESIS |
422 |
1402 |
1.135e-41 |
1.32e-38 |
5 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
474 |
1672 |
2.297e-39 |
2.138e-36 |
6 |
REGULATION OF CELL DIFFERENTIATION |
432 |
1492 |
4.08e-38 |
3.164e-35 |
7 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
463 |
1656 |
9.487e-37 |
5.518e-34 |
8 |
CELL DEVELOPMENT |
414 |
1426 |
9.196e-37 |
5.518e-34 |
9 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
320 |
1021 |
4.621e-35 |
2.389e-32 |
10 |
BIOLOGICAL ADHESION |
318 |
1032 |
2.738e-33 |
1.274e-30 |
11 |
RESPONSE TO ENDOGENOUS STIMULUS |
408 |
1450 |
7.002e-33 |
2.962e-30 |
12 |
ORGAN MORPHOGENESIS |
273 |
841 |
9.834e-33 |
3.813e-30 |
13 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
477 |
1784 |
1.193e-32 |
4.27e-30 |
14 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
310 |
1008 |
2.824e-32 |
9.385e-30 |
15 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
255 |
771 |
4.865e-32 |
1.509e-29 |
16 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
235 |
689 |
8.226e-32 |
2.392e-29 |
17 |
EPITHELIUM DEVELOPMENT |
294 |
945 |
1.418e-31 |
3.664e-29 |
18 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
475 |
1791 |
1.366e-31 |
3.664e-29 |
19 |
HEART DEVELOPMENT |
177 |
466 |
1.679e-30 |
4.111e-28 |
20 |
POSITIVE REGULATION OF GENE EXPRESSION |
459 |
1733 |
2.469e-30 |
5.745e-28 |
21 |
REGULATION OF CELL DEVELOPMENT |
265 |
836 |
6.507e-30 |
1.442e-27 |
22 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
358 |
1275 |
1.399e-28 |
2.854e-26 |
23 |
VASCULATURE DEVELOPMENT |
174 |
469 |
1.411e-28 |
2.854e-26 |
24 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
475 |
1848 |
3.589e-28 |
6.958e-26 |
25 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
184 |
513 |
4.587e-28 |
8.538e-26 |
26 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
381 |
1395 |
7.879e-28 |
1.41e-25 |
27 |
TISSUE MORPHOGENESIS |
187 |
533 |
3.754e-27 |
6.47e-25 |
28 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
404 |
1518 |
4.785e-27 |
7.952e-25 |
29 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
323 |
1142 |
2.275e-26 |
3.65e-24 |
30 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
236 |
750 |
3.444e-26 |
5.342e-24 |
31 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
438 |
1710 |
1.462e-25 |
2.194e-23 |
32 |
LOCOMOTION |
314 |
1114 |
2.298e-25 |
3.342e-23 |
33 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
280 |
957 |
2.408e-25 |
3.395e-23 |
34 |
INTRACELLULAR SIGNAL TRANSDUCTION |
409 |
1572 |
2.945e-25 |
4.031e-23 |
35 |
CELLULAR COMPONENT MORPHOGENESIS |
267 |
900 |
3.563e-25 |
4.736e-23 |
36 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
414 |
1618 |
4.931e-24 |
6.373e-22 |
37 |
MUSCLE STRUCTURE DEVELOPMENT |
155 |
432 |
8.075e-24 |
1.015e-21 |
38 |
REGULATION OF CELL MORPHOGENESIS |
184 |
552 |
9.332e-24 |
1.143e-21 |
39 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
360 |
1360 |
1.286e-23 |
1.534e-21 |
40 |
PROTEIN PHOSPHORYLATION |
272 |
944 |
1.518e-23 |
1.766e-21 |
41 |
BLOOD VESSEL MORPHOGENESIS |
137 |
364 |
2.061e-23 |
2.339e-21 |
42 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
449 |
1805 |
2.164e-23 |
2.397e-21 |
43 |
NEURON DIFFERENTIATION |
256 |
874 |
2.729e-23 |
2.953e-21 |
44 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
324 |
1192 |
2.808e-23 |
2.969e-21 |
45 |
REGULATION OF TRANSPORT |
448 |
1804 |
3.515e-23 |
3.634e-21 |
46 |
REGULATION OF CELL PROJECTION ORGANIZATION |
184 |
558 |
3.772e-23 |
3.816e-21 |
47 |
REGULATION OF CELL PROLIFERATION |
386 |
1496 |
4.233e-23 |
4.191e-21 |
48 |
POSITIVE REGULATION OF CELL COMMUNICATION |
393 |
1532 |
5.1e-23 |
4.944e-21 |
49 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
283 |
1004 |
6.795e-23 |
6.453e-21 |
50 |
REGULATION OF GTPASE ACTIVITY |
210 |
673 |
6.986e-23 |
6.502e-21 |
51 |
REGULATION OF NEURON DIFFERENTIATION |
182 |
554 |
1.054e-22 |
9.617e-21 |
52 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
470 |
1929 |
1.653e-22 |
1.479e-20 |
53 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
260 |
905 |
2.463e-22 |
2.162e-20 |
54 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
112 |
278 |
4.169e-22 |
3.592e-20 |
55 |
REGULATION OF HYDROLASE ACTIVITY |
347 |
1327 |
8.427e-22 |
7.13e-20 |
56 |
RESPONSE TO GROWTH FACTOR |
160 |
475 |
2.592e-21 |
2.154e-19 |
57 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
239 |
823 |
2.982e-21 |
2.434e-19 |
58 |
MORPHOGENESIS OF AN EPITHELIUM |
141 |
400 |
5.917e-21 |
4.747e-19 |
59 |
TUBE DEVELOPMENT |
177 |
552 |
7.834e-21 |
6.178e-19 |
60 |
EMBRYO DEVELOPMENT |
253 |
894 |
8.769e-21 |
6.801e-19 |
61 |
CELL MOTILITY |
240 |
835 |
1.064e-20 |
7.989e-19 |
62 |
LOCALIZATION OF CELL |
240 |
835 |
1.064e-20 |
7.989e-19 |
63 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
164 |
498 |
1.102e-20 |
8.14e-19 |
64 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
354 |
1381 |
1.125e-20 |
8.176e-19 |
65 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
124 |
337 |
2.404e-20 |
1.721e-18 |
66 |
NEURON PROJECTION DEVELOPMENT |
174 |
545 |
2.812e-20 |
1.983e-18 |
67 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
470 |
1977 |
3.151e-20 |
2.188e-18 |
68 |
UROGENITAL SYSTEM DEVELOPMENT |
114 |
299 |
3.29e-20 |
2.251e-18 |
69 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
305 |
1152 |
4.65e-20 |
3.136e-18 |
70 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
140 |
408 |
1.315e-19 |
8.738e-18 |
71 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
244 |
872 |
2.198e-19 |
1.441e-17 |
72 |
HEAD DEVELOPMENT |
208 |
709 |
3.667e-19 |
2.37e-17 |
73 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
227 |
799 |
5.928e-19 |
3.778e-17 |
74 |
REGULATION OF CELL DEATH |
364 |
1472 |
1.72e-18 |
1.081e-16 |
75 |
POSITIVE REGULATION OF LOCOMOTION |
140 |
420 |
2.393e-18 |
1.484e-16 |
76 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
275 |
1036 |
2.627e-18 |
1.587e-16 |
77 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
275 |
1036 |
2.627e-18 |
1.587e-16 |
78 |
SKELETAL SYSTEM DEVELOPMENT |
148 |
455 |
3.11e-18 |
1.855e-16 |
79 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
106 |
285 |
5.67e-18 |
3.339e-16 |
80 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
294 |
1135 |
6.473e-18 |
3.765e-16 |
81 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
240 |
876 |
7.516e-18 |
4.318e-16 |
82 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
91 |
229 |
9.343e-18 |
5.301e-16 |
83 |
NEURON DEVELOPMENT |
199 |
687 |
1.019e-17 |
5.711e-16 |
84 |
RESPONSE TO HORMONE |
243 |
893 |
1.138e-17 |
6.232e-16 |
85 |
PHOSPHORYLATION |
312 |
1228 |
1.136e-17 |
6.232e-16 |
86 |
GROWTH |
136 |
410 |
1.174e-17 |
6.35e-16 |
87 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
210 |
740 |
1.516e-17 |
8.107e-16 |
88 |
REGULATION OF KINASE ACTIVITY |
217 |
776 |
2.638e-17 |
1.395e-15 |
89 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
149 |
472 |
4.795e-17 |
2.507e-15 |
90 |
DEVELOPMENTAL GROWTH |
116 |
333 |
5.043e-17 |
2.607e-15 |
91 |
EMBRYONIC MORPHOGENESIS |
164 |
539 |
6.039e-17 |
3.088e-15 |
92 |
CELL PROJECTION ORGANIZATION |
242 |
902 |
8.436e-17 |
4.267e-15 |
93 |
REGULATION OF MAPK CASCADE |
189 |
660 |
2.499e-16 |
1.25e-14 |
94 |
ACTIN FILAMENT BASED PROCESS |
142 |
450 |
2.744e-16 |
1.358e-14 |
95 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
219 |
801 |
2.904e-16 |
1.422e-14 |
96 |
FOREBRAIN DEVELOPMENT |
120 |
357 |
3.211e-16 |
1.556e-14 |
97 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
358 |
1492 |
4.686e-16 |
2.248e-14 |
98 |
TUBE MORPHOGENESIS |
111 |
323 |
7.19e-16 |
3.414e-14 |
99 |
MESENCHYME DEVELOPMENT |
77 |
190 |
8.459e-16 |
3.936e-14 |
100 |
STEM CELL DIFFERENTIATION |
77 |
190 |
8.459e-16 |
3.936e-14 |
101 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
108 |
312 |
1.002e-15 |
4.604e-14 |
102 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
255 |
983 |
1.009e-15 |
4.604e-14 |
103 |
RESPONSE TO NITROGEN COMPOUND |
229 |
859 |
1.297e-15 |
5.86e-14 |
104 |
RESPONSE TO LIPID |
235 |
888 |
1.322e-15 |
5.915e-14 |
105 |
ANGIOGENESIS |
103 |
293 |
1.433e-15 |
6.349e-14 |
106 |
MUSCLE ORGAN DEVELOPMENT |
99 |
277 |
1.49e-15 |
6.542e-14 |
107 |
REGULATION OF SYSTEM PROCESS |
153 |
507 |
1.509e-15 |
6.563e-14 |
108 |
NEURON PROJECTION MORPHOGENESIS |
129 |
402 |
1.53e-15 |
6.593e-14 |
109 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
209 |
767 |
2.111e-15 |
9.013e-14 |
110 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
160 |
541 |
2.442e-15 |
1.024e-13 |
111 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
160 |
541 |
2.442e-15 |
1.024e-13 |
112 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
240 |
917 |
2.541e-15 |
1.056e-13 |
113 |
SENSORY ORGAN DEVELOPMENT |
149 |
493 |
3.1e-15 |
1.276e-13 |
114 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
162 |
552 |
3.463e-15 |
1.413e-13 |
115 |
NEGATIVE REGULATION OF GENE EXPRESSION |
354 |
1493 |
4.403e-15 |
1.782e-13 |
116 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
151 |
505 |
5.497e-15 |
2.205e-13 |
117 |
REGULATION OF EPITHELIAL CELL MIGRATION |
69 |
166 |
5.782e-15 |
2.299e-13 |
118 |
MESENCHYMAL CELL DIFFERENTIATION |
60 |
134 |
5.856e-15 |
2.309e-13 |
119 |
PALATE DEVELOPMENT |
45 |
85 |
6.85e-15 |
2.679e-13 |
120 |
MUSCLE TISSUE DEVELOPMENT |
97 |
275 |
7.516e-15 |
2.914e-13 |
121 |
HEART MORPHOGENESIS |
81 |
212 |
8.061e-15 |
3.1e-13 |
122 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
119 |
368 |
1.042e-14 |
3.976e-13 |
123 |
POSITIVE REGULATION OF KINASE ACTIVITY |
145 |
482 |
1.118e-14 |
4.23e-13 |
124 |
MUSCLE CELL DIFFERENTIATION |
87 |
237 |
1.298e-14 |
4.869e-13 |
125 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
127 |
404 |
1.443e-14 |
5.371e-13 |
126 |
POSITIVE REGULATION OF CELL PROLIFERATION |
216 |
814 |
1.474e-14 |
5.445e-13 |
127 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
172 |
609 |
2.28e-14 |
8.355e-13 |
128 |
NEGATIVE REGULATION OF CELL DEATH |
227 |
872 |
2.817e-14 |
1.024e-12 |
129 |
POSITIVE REGULATION OF MAPK CASCADE |
141 |
470 |
3.332e-14 |
1.202e-12 |
130 |
CONNECTIVE TISSUE DEVELOPMENT |
75 |
194 |
3.858e-14 |
1.381e-12 |
131 |
BEHAVIOR |
151 |
516 |
3.971e-14 |
1.411e-12 |
132 |
RESPONSE TO WOUNDING |
161 |
563 |
4.98e-14 |
1.755e-12 |
133 |
EMBRYONIC ORGAN DEVELOPMENT |
126 |
406 |
5.256e-14 |
1.839e-12 |
134 |
REGULATION OF CELL ADHESION |
175 |
629 |
5.931e-14 |
2.059e-12 |
135 |
GLAND DEVELOPMENT |
123 |
395 |
8.049e-14 |
2.774e-12 |
136 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
129 |
422 |
9.134e-14 |
3.125e-12 |
137 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
158 |
554 |
1.103e-13 |
3.745e-12 |
138 |
SINGLE ORGANISM BEHAVIOR |
120 |
384 |
1.229e-13 |
4.145e-12 |
139 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
132 |
437 |
1.264e-13 |
4.231e-12 |
140 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
139 |
470 |
1.714e-13 |
5.698e-12 |
141 |
CELL CELL ADHESION |
169 |
608 |
1.769e-13 |
5.838e-12 |
142 |
REGULATION OF TRANSFERASE ACTIVITY |
239 |
946 |
1.907e-13 |
6.235e-12 |
143 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
77 |
207 |
1.916e-13 |
6.235e-12 |
144 |
REGULATION OF DEVELOPMENTAL GROWTH |
97 |
289 |
2.486e-13 |
8.034e-12 |
145 |
REGULATION OF CELLULAR LOCALIZATION |
304 |
1277 |
2.822e-13 |
9.055e-12 |
146 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
72 |
190 |
3.989e-13 |
1.271e-11 |
147 |
POSITIVE REGULATION OF TRANSPORT |
235 |
936 |
6.198e-13 |
1.962e-11 |
148 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
348 |
1517 |
9.166e-13 |
2.882e-11 |
149 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
174 |
643 |
9.825e-13 |
3.068e-11 |
150 |
EPITHELIAL CELL DIFFERENTIATION |
142 |
495 |
1.226e-12 |
3.804e-11 |
151 |
TAXIS |
135 |
464 |
1.445e-12 |
4.451e-11 |
152 |
ENDOMEMBRANE SYSTEM ORGANIZATION |
135 |
465 |
1.716e-12 |
5.253e-11 |
153 |
REGULATION OF GROWTH |
171 |
633 |
1.814e-12 |
5.516e-11 |
154 |
REGULATION OF AXONOGENESIS |
65 |
168 |
1.826e-12 |
5.516e-11 |
155 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
69 |
184 |
2.179e-12 |
6.541e-11 |
156 |
TELENCEPHALON DEVELOPMENT |
80 |
228 |
2.322e-12 |
6.883e-11 |
157 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
98 |
303 |
2.312e-12 |
6.883e-11 |
158 |
MUSCLE SYSTEM PROCESS |
93 |
282 |
2.423e-12 |
7.135e-11 |
159 |
STRIATED MUSCLE CELL DIFFERENTIATION |
66 |
173 |
2.627e-12 |
7.689e-11 |
160 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
61 |
154 |
2.655e-12 |
7.722e-11 |
161 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
98 |
304 |
2.876e-12 |
8.312e-11 |
162 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
88 |
262 |
3.034e-12 |
8.715e-11 |
163 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
63 |
162 |
3.059e-12 |
8.733e-11 |
164 |
SKELETAL SYSTEM MORPHOGENESIS |
73 |
201 |
3.137e-12 |
8.901e-11 |
165 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
47 |
104 |
3.305e-12 |
9.32e-11 |
166 |
REGULATION OF OSSIFICATION |
67 |
178 |
3.706e-12 |
1.039e-10 |
167 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
98 |
306 |
4.43e-12 |
1.234e-10 |
168 |
REGULATION OF MAP KINASE ACTIVITY |
101 |
319 |
4.505e-12 |
1.248e-10 |
169 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
127 |
437 |
7.276e-12 |
2.003e-10 |
170 |
EMBRYONIC ORGAN MORPHOGENESIS |
91 |
279 |
8.312e-12 |
2.275e-10 |
171 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
46 |
103 |
9.353e-12 |
2.545e-10 |
172 |
CARDIAC CHAMBER DEVELOPMENT |
57 |
144 |
1.413e-11 |
3.824e-10 |
173 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
63 |
167 |
1.445e-11 |
3.886e-10 |
174 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
164 |
616 |
1.839e-11 |
4.889e-10 |
175 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
164 |
616 |
1.839e-11 |
4.889e-10 |
176 |
CELLULAR RESPONSE TO LIPID |
130 |
457 |
2.083e-11 |
5.507e-10 |
177 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
55 |
138 |
2.337e-11 |
6.143e-10 |
178 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
133 |
472 |
2.507e-11 |
6.555e-10 |
179 |
RHYTHMIC PROCESS |
94 |
298 |
3.112e-11 |
8.089e-10 |
180 |
RESPONSE TO STEROID HORMONE |
138 |
497 |
3.299e-11 |
8.528e-10 |
181 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
131 |
465 |
3.598e-11 |
9.249e-10 |
182 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
50 |
121 |
3.957e-11 |
1.012e-09 |
183 |
REGULATION OF CELL SUBSTRATE ADHESION |
63 |
173 |
8.274e-11 |
2.104e-09 |
184 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
94 |
303 |
8.611e-11 |
2.178e-09 |
185 |
CELL DEATH |
239 |
1001 |
8.861e-11 |
2.229e-09 |
186 |
EYE DEVELOPMENT |
99 |
326 |
1.046e-10 |
2.616e-09 |
187 |
NEGATIVE REGULATION OF TRANSPORT |
128 |
458 |
1.075e-10 |
2.674e-09 |
188 |
CARTILAGE DEVELOPMENT |
56 |
147 |
1.241e-10 |
3.071e-09 |
189 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
77 |
232 |
1.3e-10 |
3.2e-09 |
190 |
REGULATION OF PROTEIN LOCALIZATION |
228 |
950 |
1.481e-10 |
3.628e-09 |
191 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
54 |
140 |
1.533e-10 |
3.735e-09 |
192 |
REGULATION OF CELLULAR COMPONENT SIZE |
101 |
337 |
1.553e-10 |
3.764e-09 |
193 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
55 |
144 |
1.613e-10 |
3.889e-09 |
194 |
COGNITION |
81 |
251 |
2.066e-10 |
4.929e-09 |
195 |
POSITIVE REGULATION OF CELL DEATH |
158 |
605 |
2.059e-10 |
4.929e-09 |
196 |
SYNAPSE ORGANIZATION |
55 |
145 |
2.192e-10 |
5.205e-09 |
197 |
PALLIUM DEVELOPMENT |
57 |
153 |
2.345e-10 |
5.538e-09 |
198 |
REGULATION OF BLOOD CIRCULATION |
91 |
295 |
2.389e-10 |
5.614e-09 |
199 |
SENSORY ORGAN MORPHOGENESIS |
78 |
239 |
2.446e-10 |
5.719e-09 |
200 |
REGULATION OF CELL MATRIX ADHESION |
40 |
90 |
2.492e-10 |
5.798e-09 |
201 |
REGULATION OF ION TRANSPORT |
155 |
592 |
2.51e-10 |
5.811e-09 |
202 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
222 |
926 |
2.905e-10 |
6.691e-09 |
203 |
REGULATION OF TRANSPORTER ACTIVITY |
68 |
198 |
2.94e-10 |
6.74e-09 |
204 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
87 |
279 |
3.217e-10 |
7.338e-09 |
205 |
REGULATION OF HEART CONTRACTION |
73 |
221 |
4.963e-10 |
1.127e-08 |
206 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
174 |
691 |
5.45e-10 |
1.231e-08 |
207 |
KIDNEY EPITHELIUM DEVELOPMENT |
49 |
125 |
5.563e-10 |
1.25e-08 |
208 |
NEURON PROJECTION GUIDANCE |
69 |
205 |
5.908e-10 |
1.322e-08 |
209 |
PROTEIN LOCALIZATION |
387 |
1805 |
6.221e-10 |
1.385e-08 |
210 |
WOUND HEALING |
128 |
470 |
6.624e-10 |
1.468e-08 |
211 |
CELL JUNCTION ORGANIZATION |
64 |
185 |
6.913e-10 |
1.525e-08 |
212 |
VASCULOGENESIS |
30 |
59 |
7.836e-10 |
1.72e-08 |
213 |
WNT SIGNALING PATHWAY |
102 |
351 |
8.442e-10 |
1.844e-08 |
214 |
NEGATIVE REGULATION OF LOCOMOTION |
82 |
263 |
1.037e-09 |
2.254e-08 |
215 |
CIRCULATORY SYSTEM PROCESS |
105 |
366 |
1.055e-09 |
2.273e-08 |
216 |
SINGLE ORGANISM CELL ADHESION |
125 |
459 |
1.052e-09 |
2.273e-08 |
217 |
REGULATION OF MUSCLE SYSTEM PROCESS |
66 |
195 |
1.067e-09 |
2.289e-08 |
218 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
45 |
112 |
1.093e-09 |
2.333e-08 |
219 |
CELL PART MORPHOGENESIS |
161 |
633 |
1.126e-09 |
2.393e-08 |
220 |
RESPONSE TO ALCOHOL |
104 |
362 |
1.162e-09 |
2.457e-08 |
221 |
RESPONSE TO PEPTIDE |
113 |
404 |
1.261e-09 |
2.632e-08 |
222 |
CEREBRAL CORTEX DEVELOPMENT |
43 |
105 |
1.26e-09 |
2.632e-08 |
223 |
ODONTOGENESIS |
43 |
105 |
1.26e-09 |
2.632e-08 |
224 |
OSSIFICATION |
79 |
251 |
1.281e-09 |
2.662e-08 |
225 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
41 |
98 |
1.412e-09 |
2.92e-08 |
226 |
CELLULAR RESPONSE TO PEPTIDE |
84 |
274 |
1.617e-09 |
3.329e-08 |
227 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
53 |
144 |
1.64e-09 |
3.361e-08 |
228 |
DIGESTIVE SYSTEM DEVELOPMENT |
54 |
148 |
1.663e-09 |
3.394e-08 |
229 |
BONE DEVELOPMENT |
56 |
156 |
1.681e-09 |
3.415e-08 |
230 |
CELL PROLIFERATION |
168 |
672 |
1.922e-09 |
3.888e-08 |
231 |
CYTOSKELETON ORGANIZATION |
201 |
838 |
2.005e-09 |
4.038e-08 |
232 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
41 |
99 |
2.034e-09 |
4.062e-08 |
233 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
41 |
99 |
2.034e-09 |
4.062e-08 |
234 |
CHEMICAL HOMEOSTASIS |
208 |
874 |
2.086e-09 |
4.148e-08 |
235 |
REGULATION OF MEMBRANE POTENTIAL |
99 |
343 |
2.215e-09 |
4.385e-08 |
236 |
REGULATION OF METAL ION TRANSPORT |
95 |
325 |
2.282e-09 |
4.5e-08 |
237 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
249 |
1087 |
2.416e-09 |
4.744e-08 |
238 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
47 |
122 |
2.432e-09 |
4.754e-08 |
239 |
MUSCLE CONTRACTION |
74 |
233 |
2.719e-09 |
5.293e-08 |
240 |
AMEBOIDAL TYPE CELL MIGRATION |
55 |
154 |
2.897e-09 |
5.617e-08 |
241 |
REGULATION OF ORGAN MORPHOGENESIS |
76 |
242 |
2.925e-09 |
5.647e-08 |
242 |
REGULATION OF CELL GROWTH |
109 |
391 |
3.022e-09 |
5.811e-08 |
243 |
GLAND MORPHOGENESIS |
40 |
97 |
3.701e-09 |
7.087e-08 |
244 |
REGULATION OF RESPONSE TO STRESS |
320 |
1468 |
3.749e-09 |
7.149e-08 |
245 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
177 |
724 |
4.29e-09 |
8.147e-08 |
246 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
65 |
197 |
4.563e-09 |
8.589e-08 |
247 |
HOMEOSTATIC PROCESS |
295 |
1337 |
4.578e-09 |
8.589e-08 |
248 |
REGULATION OF CELL SIZE |
59 |
172 |
4.547e-09 |
8.589e-08 |
249 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
28 |
56 |
4.683e-09 |
8.715e-08 |
250 |
MUSCLE CELL DEVELOPMENT |
48 |
128 |
4.678e-09 |
8.715e-08 |
251 |
CELL SUBSTRATE ADHESION |
57 |
164 |
4.776e-09 |
8.819e-08 |
252 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
112 |
408 |
4.759e-09 |
8.819e-08 |
253 |
IMMUNE SYSTEM DEVELOPMENT |
148 |
582 |
5.393e-09 |
9.918e-08 |
254 |
CELL ACTIVATION |
145 |
568 |
5.879e-09 |
1.076e-07 |
255 |
RESPONSE TO EXTERNAL STIMULUS |
384 |
1821 |
5.918e-09 |
1.076e-07 |
256 |
CELLULAR MACROMOLECULE LOCALIZATION |
275 |
1234 |
5.903e-09 |
1.076e-07 |
257 |
APPENDAGE DEVELOPMENT |
58 |
169 |
5.996e-09 |
1.081e-07 |
258 |
LIMB DEVELOPMENT |
58 |
169 |
5.996e-09 |
1.081e-07 |
259 |
ACTOMYOSIN STRUCTURE ORGANIZATION |
34 |
77 |
6.662e-09 |
1.194e-07 |
260 |
REGULATION OF VASCULATURE DEVELOPMENT |
73 |
233 |
6.671e-09 |
1.194e-07 |
261 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
57 |
166 |
7.908e-09 |
1.41e-07 |
262 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
115 |
426 |
8.36e-09 |
1.485e-07 |
263 |
REGULATION OF BINDING |
84 |
283 |
8.745e-09 |
1.547e-07 |
264 |
CARDIAC SEPTUM DEVELOPMENT |
36 |
85 |
9.439e-09 |
1.664e-07 |
265 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
99 |
352 |
9.688e-09 |
1.701e-07 |
266 |
REGULATION OF JNK CASCADE |
55 |
159 |
1.07e-08 |
1.872e-07 |
267 |
REGULATION OF HOMEOSTATIC PROCESS |
119 |
447 |
1.102e-08 |
1.921e-07 |
268 |
HEAD MORPHOGENESIS |
21 |
36 |
1.107e-08 |
1.923e-07 |
269 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
48 |
131 |
1.12e-08 |
1.938e-07 |
270 |
REGULATION OF CYTOPLASMIC TRANSPORT |
126 |
481 |
1.163e-08 |
2.005e-07 |
271 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
31 |
68 |
1.208e-08 |
2.075e-07 |
272 |
REGULATION OF BODY FLUID LEVELS |
131 |
506 |
1.293e-08 |
2.211e-07 |
273 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
110 |
406 |
1.419e-08 |
2.418e-07 |
274 |
INOSITOL LIPID MEDIATED SIGNALING |
46 |
124 |
1.44e-08 |
2.446e-07 |
275 |
DENDRITE DEVELOPMENT |
34 |
79 |
1.48e-08 |
2.504e-07 |
276 |
RESPONSE TO ABIOTIC STIMULUS |
233 |
1024 |
1.487e-08 |
2.507e-07 |
277 |
ION TRANSPORT |
278 |
1262 |
1.554e-08 |
2.61e-07 |
278 |
ACTIVATION OF MAPKK ACTIVITY |
26 |
52 |
1.658e-08 |
2.776e-07 |
279 |
REGULATION OF ORGANELLE ORGANIZATION |
262 |
1178 |
1.676e-08 |
2.796e-07 |
280 |
PLASMA MEMBRANE ORGANIZATION |
65 |
203 |
1.724e-08 |
2.865e-07 |
281 |
PEPTIDYL TYROSINE MODIFICATION |
61 |
186 |
1.736e-08 |
2.865e-07 |
282 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
29 |
62 |
1.734e-08 |
2.865e-07 |
283 |
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
53 |
153 |
1.86e-08 |
3.058e-07 |
284 |
PATTERN SPECIFICATION PROCESS |
112 |
418 |
2.03e-08 |
3.326e-07 |
285 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
40 |
102 |
2.044e-08 |
3.338e-07 |
286 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
62 |
191 |
2.058e-08 |
3.346e-07 |
287 |
VESICLE MEDIATED TRANSPORT |
273 |
1239 |
2.064e-08 |
3.346e-07 |
288 |
CARDIAC VENTRICLE DEVELOPMENT |
41 |
106 |
2.177e-08 |
3.517e-07 |
289 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
43 |
114 |
2.387e-08 |
3.843e-07 |
290 |
POSITIVE REGULATION OF OSSIFICATION |
35 |
84 |
2.505e-08 |
4.019e-07 |
291 |
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY |
26 |
53 |
2.754e-08 |
4.403e-07 |
292 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
40 |
103 |
2.822e-08 |
4.497e-07 |
293 |
RESPIRATORY SYSTEM DEVELOPMENT |
63 |
197 |
2.996e-08 |
4.757e-07 |
294 |
RESPONSE TO INORGANIC SUBSTANCE |
124 |
479 |
3.166e-08 |
5.011e-07 |
295 |
NEPHRON DEVELOPMENT |
43 |
115 |
3.219e-08 |
5.077e-07 |
296 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
28 |
60 |
3.246e-08 |
5.102e-07 |
297 |
CELL GROWTH |
48 |
135 |
3.379e-08 |
5.293e-07 |
298 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
39 |
100 |
3.655e-08 |
5.707e-07 |
299 |
REGULATION OF SECRETION |
168 |
699 |
3.764e-08 |
5.857e-07 |
300 |
BODY MORPHOGENESIS |
23 |
44 |
3.785e-08 |
5.871e-07 |
301 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
85 |
296 |
3.814e-08 |
5.896e-07 |
302 |
CARDIAC CHAMBER MORPHOGENESIS |
40 |
104 |
3.873e-08 |
5.967e-07 |
303 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
62 |
194 |
3.949e-08 |
6.064e-07 |
304 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
29 |
64 |
4.199e-08 |
6.427e-07 |
305 |
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION |
16 |
24 |
4.368e-08 |
6.664e-07 |
306 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
65 |
208 |
4.898e-08 |
7.448e-07 |
307 |
REGULATION OF INTRACELLULAR TRANSPORT |
152 |
621 |
4.964e-08 |
7.524e-07 |
308 |
NEURAL CREST CELL DIFFERENTIATION |
32 |
75 |
5.01e-08 |
7.568e-07 |
309 |
REGULATION OF EXTENT OF CELL GROWTH |
39 |
101 |
5.028e-08 |
7.572e-07 |
310 |
NEURAL CREST CELL MIGRATION |
25 |
51 |
5.184e-08 |
7.781e-07 |
311 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
64 |
204 |
5.256e-08 |
7.864e-07 |
312 |
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
41 |
109 |
5.49e-08 |
8.188e-07 |
313 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
49 |
141 |
5.62e-08 |
8.354e-07 |
314 |
MAMMARY GLAND DEVELOPMENT |
43 |
117 |
5.764e-08 |
8.542e-07 |
315 |
DIGESTIVE TRACT MORPHOGENESIS |
24 |
48 |
5.886e-08 |
8.694e-07 |
316 |
CELL FATE COMMITMENT |
69 |
227 |
6.522e-08 |
9.603e-07 |
317 |
NEGATIVE REGULATION OF NEURON DEATH |
56 |
171 |
6.95e-08 |
1.02e-06 |
318 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
50 |
146 |
7.047e-08 |
1.031e-06 |
319 |
REGULATION OF CATABOLIC PROCESS |
173 |
731 |
7.332e-08 |
1.066e-06 |
320 |
RESPONSE TO MECHANICAL STIMULUS |
65 |
210 |
7.325e-08 |
1.066e-06 |
321 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
74 |
250 |
7.443e-08 |
1.079e-06 |
322 |
NEGATIVE CHEMOTAXIS |
21 |
39 |
7.536e-08 |
1.089e-06 |
323 |
REGULATION OF CHEMOTAXIS |
58 |
180 |
7.757e-08 |
1.117e-06 |
324 |
POSITIVE REGULATION OF AXONOGENESIS |
30 |
69 |
7.803e-08 |
1.117e-06 |
325 |
SYNAPSE ASSEMBLY |
30 |
69 |
7.803e-08 |
1.117e-06 |
326 |
REGULATION OF WNT SIGNALING PATHWAY |
87 |
310 |
8.318e-08 |
1.187e-06 |
327 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
39 |
103 |
9.346e-08 |
1.33e-06 |
328 |
IN UTERO EMBRYONIC DEVELOPMENT |
87 |
311 |
9.737e-08 |
1.381e-06 |
329 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
24 |
49 |
9.764e-08 |
1.381e-06 |
330 |
RESPONSE TO CALCIUM ION |
42 |
115 |
1.005e-07 |
1.417e-06 |
331 |
MULTICELLULAR ORGANISMAL SIGNALING |
44 |
123 |
1.013e-07 |
1.423e-06 |
332 |
REGULATION OF STEM CELL PROLIFERATION |
35 |
88 |
1.016e-07 |
1.424e-06 |
333 |
DEVELOPMENTAL CELL GROWTH |
32 |
77 |
1.058e-07 |
1.478e-06 |
334 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
26 |
56 |
1.138e-07 |
1.581e-06 |
335 |
OUTFLOW TRACT MORPHOGENESIS |
26 |
56 |
1.138e-07 |
1.581e-06 |
336 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
30 |
70 |
1.155e-07 |
1.599e-06 |
337 |
CELL CELL SIGNALING |
179 |
767 |
1.218e-07 |
1.682e-06 |
338 |
EYE MORPHOGENESIS |
47 |
136 |
1.26e-07 |
1.735e-06 |
339 |
FEMALE SEX DIFFERENTIATION |
42 |
116 |
1.33e-07 |
1.826e-06 |
340 |
REGULATION OF CALCIUM ION TRANSPORT |
64 |
209 |
1.427e-07 |
1.953e-06 |
341 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
238 |
1079 |
1.6e-07 |
2.184e-06 |
342 |
NEGATIVE REGULATION OF CELL ADHESION |
67 |
223 |
1.635e-07 |
2.225e-06 |
343 |
REGULATION OF ION HOMEOSTASIS |
62 |
201 |
1.665e-07 |
2.258e-06 |
344 |
CELL JUNCTION ASSEMBLY |
45 |
129 |
1.699e-07 |
2.298e-06 |
345 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
60 |
193 |
1.932e-07 |
2.606e-06 |
346 |
ENDOTHELIUM DEVELOPMENT |
35 |
90 |
1.957e-07 |
2.624e-06 |
347 |
MESONEPHROS DEVELOPMENT |
35 |
90 |
1.957e-07 |
2.624e-06 |
348 |
RESPONSE TO OXYGEN LEVELS |
86 |
311 |
2.001e-07 |
2.675e-06 |
349 |
RESPONSE TO BMP |
36 |
94 |
2.066e-07 |
2.746e-06 |
350 |
CELLULAR RESPONSE TO BMP STIMULUS |
36 |
94 |
2.066e-07 |
2.746e-06 |
351 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
81 |
289 |
2.435e-07 |
3.228e-06 |
352 |
COLLAGEN FIBRIL ORGANIZATION |
20 |
38 |
2.535e-07 |
3.351e-06 |
353 |
SECOND MESSENGER MEDIATED SIGNALING |
52 |
160 |
2.637e-07 |
3.476e-06 |
354 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
51 |
156 |
2.784e-07 |
3.66e-06 |
355 |
LIPID PHOSPHORYLATION |
37 |
99 |
2.906e-07 |
3.806e-06 |
356 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
135 |
552 |
2.912e-07 |
3.806e-06 |
357 |
LEUKOCYTE ACTIVATION |
107 |
414 |
2.986e-07 |
3.891e-06 |
358 |
LIPID TRANSLOCATION |
14 |
21 |
3.151e-07 |
4.096e-06 |
359 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
25 |
55 |
3.309e-07 |
4.289e-06 |
360 |
REGULATION OF ORGAN GROWTH |
30 |
73 |
3.518e-07 |
4.546e-06 |
361 |
RESPONSE TO INSULIN |
62 |
205 |
3.607e-07 |
4.65e-06 |
362 |
REGULATION OF NEURON APOPTOTIC PROCESS |
59 |
192 |
3.781e-07 |
4.859e-06 |
363 |
CARDIOCYTE DIFFERENTIATION |
36 |
96 |
3.8e-07 |
4.87e-06 |
364 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
28 |
66 |
3.91e-07 |
4.971e-06 |
365 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
28 |
66 |
3.91e-07 |
4.971e-06 |
366 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
37 |
100 |
3.897e-07 |
4.971e-06 |
367 |
IMMUNE SYSTEM PROCESS |
401 |
1984 |
4.131e-07 |
5.237e-06 |
368 |
MUSCLE ORGAN MORPHOGENESIS |
29 |
70 |
4.478e-07 |
5.662e-06 |
369 |
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL |
11 |
14 |
4.521e-07 |
5.701e-06 |
370 |
REGULATION OF CARDIAC MUSCLE CELL CONTRACTION |
16 |
27 |
4.737e-07 |
5.957e-06 |
371 |
PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS |
23 |
49 |
4.775e-07 |
5.958e-06 |
372 |
GLOMERULUS DEVELOPMENT |
23 |
49 |
4.775e-07 |
5.958e-06 |
373 |
POST EMBRYONIC DEVELOPMENT |
34 |
89 |
4.776e-07 |
5.958e-06 |
374 |
REGULATION OF CARTILAGE DEVELOPMENT |
27 |
63 |
4.91e-07 |
6.093e-06 |
375 |
REGULATION OF MUSCLE ADAPTATION |
27 |
63 |
4.91e-07 |
6.093e-06 |
376 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
35 |
93 |
4.966e-07 |
6.146e-06 |
377 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
30 |
74 |
5.003e-07 |
6.172e-06 |
378 |
EMBRYONIC EYE MORPHOGENESIS |
18 |
33 |
5.014e-07 |
6.172e-06 |
379 |
REGULATION OF CYTOSKELETON ORGANIZATION |
124 |
502 |
5.037e-07 |
6.184e-06 |
380 |
REGULATION OF RECEPTOR ACTIVITY |
41 |
117 |
5.137e-07 |
6.29e-06 |
381 |
SEX DIFFERENTIATION |
75 |
266 |
5.19e-07 |
6.339e-06 |
382 |
OVULATION CYCLE |
40 |
113 |
5.207e-07 |
6.342e-06 |
383 |
EMBRYONIC CRANIAL SKELETON MORPHOGENESIS |
22 |
46 |
5.635e-07 |
6.845e-06 |
384 |
PROTEIN LOCALIZATION TO CELL PERIPHERY |
49 |
151 |
6.065e-07 |
7.35e-06 |
385 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
24 |
53 |
6.183e-07 |
7.472e-06 |
386 |
REGULATION OF HEART RATE |
33 |
86 |
6.219e-07 |
7.496e-06 |
387 |
RESPONSE TO METAL ION |
89 |
333 |
6.295e-07 |
7.569e-06 |
388 |
MORPHOGENESIS OF AN EPITHELIAL SHEET |
21 |
43 |
6.55e-07 |
7.855e-06 |
389 |
EAR DEVELOPMENT |
59 |
195 |
6.739e-07 |
8.061e-06 |
390 |
RESPONSE TO KETONE |
56 |
182 |
7.055e-07 |
8.418e-06 |
391 |
REGULATION OF CELL SHAPE |
46 |
139 |
7.093e-07 |
8.44e-06 |
392 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
45 |
135 |
7.425e-07 |
8.791e-06 |
393 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
45 |
135 |
7.425e-07 |
8.791e-06 |
394 |
ION HOMEOSTASIS |
138 |
576 |
7.467e-07 |
8.819e-06 |
395 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
49 |
152 |
7.556e-07 |
8.901e-06 |
396 |
BONE MORPHOGENESIS |
31 |
79 |
7.616e-07 |
8.949e-06 |
397 |
REGIONALIZATION |
84 |
311 |
8.057e-07 |
9.443e-06 |
398 |
REGULATION OF LIPASE ACTIVITY |
32 |
83 |
8.09e-07 |
9.458e-06 |
399 |
ORGAN GROWTH |
28 |
68 |
8.172e-07 |
9.507e-06 |
400 |
NERVE DEVELOPMENT |
28 |
68 |
8.172e-07 |
9.507e-06 |
401 |
TISSUE REMODELING |
33 |
87 |
8.469e-07 |
9.827e-06 |
402 |
ENSHEATHMENT OF NEURONS |
34 |
91 |
8.754e-07 |
1.011e-05 |
403 |
AXON ENSHEATHMENT |
34 |
91 |
8.754e-07 |
1.011e-05 |
404 |
REGULATION OF RESPONSE TO WOUNDING |
105 |
413 |
8.918e-07 |
1.027e-05 |
405 |
CANONICAL WNT SIGNALING PATHWAY |
35 |
95 |
8.948e-07 |
1.028e-05 |
406 |
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
18 |
34 |
9.039e-07 |
1.033e-05 |
407 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
18 |
34 |
9.039e-07 |
1.033e-05 |
408 |
PROTEIN UBIQUITINATION |
148 |
629 |
9.194e-07 |
1.049e-05 |
409 |
VENTRICULAR SEPTUM DEVELOPMENT |
24 |
54 |
9.422e-07 |
1.072e-05 |
410 |
POSITIVE REGULATION OF GROWTH |
68 |
238 |
1.03e-06 |
1.169e-05 |
411 |
REGULATION OF NEURON DEATH |
71 |
252 |
1.063e-06 |
1.203e-05 |
412 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
64 |
220 |
1.073e-06 |
1.211e-05 |
413 |
SKIN DEVELOPMENT |
62 |
211 |
1.081e-06 |
1.218e-05 |
414 |
REGULATION OF DENDRITE DEVELOPMENT |
41 |
120 |
1.099e-06 |
1.236e-05 |
415 |
LYMPHOCYTE ACTIVATION |
90 |
342 |
1.122e-06 |
1.258e-05 |
416 |
EMBRYONIC PATTERN SPECIFICATION |
25 |
58 |
1.135e-06 |
1.27e-05 |
417 |
ESTABLISHMENT OF CELL POLARITY |
33 |
88 |
1.146e-06 |
1.278e-05 |
418 |
SKELETAL MUSCLE ORGAN DEVELOPMENT |
45 |
137 |
1.178e-06 |
1.312e-05 |
419 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
61 |
207 |
1.183e-06 |
1.314e-05 |
420 |
FOREBRAIN CELL MIGRATION |
26 |
62 |
1.32e-06 |
1.462e-05 |
421 |
REGULATION OF BMP SIGNALING PATHWAY |
30 |
77 |
1.365e-06 |
1.509e-05 |
422 |
PROTEIN DEPHOSPHORYLATION |
57 |
190 |
1.398e-06 |
1.542e-05 |
423 |
METANEPHROS DEVELOPMENT |
31 |
81 |
1.44e-06 |
1.585e-05 |
424 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
40 |
117 |
1.452e-06 |
1.594e-05 |
425 |
DIVALENT INORGANIC CATION TRANSPORT |
74 |
268 |
1.465e-06 |
1.604e-05 |
426 |
MODULATION OF SYNAPTIC TRANSMISSION |
81 |
301 |
1.473e-06 |
1.609e-05 |
427 |
POSITIVE REGULATION OF LIPASE ACTIVITY |
27 |
66 |
1.49e-06 |
1.619e-05 |
428 |
REGULATION OF CARDIAC MUSCLE CONTRACTION |
27 |
66 |
1.49e-06 |
1.619e-05 |
429 |
HEART PROCESS |
32 |
85 |
1.498e-06 |
1.625e-05 |
430 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
114 |
462 |
1.516e-06 |
1.641e-05 |
431 |
EPITHELIAL CELL DEVELOPMENT |
56 |
186 |
1.521e-06 |
1.642e-05 |
432 |
EPITHELIAL CELL PROLIFERATION |
33 |
89 |
1.539e-06 |
1.658e-05 |
433 |
ACTIN FILAMENT BASED MOVEMENT |
34 |
93 |
1.564e-06 |
1.681e-05 |
434 |
CAMERA TYPE EYE MORPHOGENESIS |
36 |
101 |
1.57e-06 |
1.683e-05 |
435 |
REGULATION OF ACTIN FILAMENT BASED MOVEMENT |
17 |
32 |
1.709e-06 |
1.828e-05 |
436 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
42 |
126 |
1.713e-06 |
1.828e-05 |
437 |
MESODERM DEVELOPMENT |
40 |
118 |
1.856e-06 |
1.976e-05 |
438 |
SOMITE DEVELOPMENT |
30 |
78 |
1.876e-06 |
1.993e-05 |
439 |
NEURON MIGRATION |
38 |
110 |
1.974e-06 |
2.092e-05 |
440 |
REGULATION OF PROTEIN IMPORT |
55 |
183 |
1.994e-06 |
2.109e-05 |
441 |
CALCIUM MEDIATED SIGNALING |
33 |
90 |
2.055e-06 |
2.16e-05 |
442 |
LEARNING |
43 |
131 |
2.057e-06 |
2.16e-05 |
443 |
RENAL SYSTEM PROCESS |
36 |
102 |
2.051e-06 |
2.16e-05 |
444 |
ACTION POTENTIAL |
34 |
94 |
2.071e-06 |
2.171e-05 |
445 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
27 |
67 |
2.111e-06 |
2.203e-05 |
446 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
27 |
67 |
2.111e-06 |
2.203e-05 |
447 |
PERICARDIUM DEVELOPMENT |
12 |
18 |
2.293e-06 |
2.387e-05 |
448 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
19 |
39 |
2.339e-06 |
2.43e-05 |
449 |
CELLULAR RESPONSE TO ACID CHEMICAL |
53 |
175 |
2.355e-06 |
2.441e-05 |
450 |
STEM CELL PROLIFERATION |
25 |
60 |
2.42e-06 |
2.502e-05 |
451 |
RESPONSE TO ACID CHEMICAL |
84 |
319 |
2.452e-06 |
2.53e-05 |
452 |
ESTABLISHMENT OF LOCALIZATION IN CELL |
340 |
1676 |
2.465e-06 |
2.538e-05 |
453 |
REGULATION OF CELL DIVISION |
74 |
272 |
2.663e-06 |
2.735e-05 |
454 |
REGULATION OF AUTOPHAGY |
69 |
249 |
2.847e-06 |
2.918e-05 |
455 |
LEUKOCYTE DIFFERENTIATION |
78 |
292 |
3.094e-06 |
3.164e-05 |
456 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
39 |
116 |
3.123e-06 |
3.187e-05 |
457 |
TRANSMEMBRANE TRANSPORT |
234 |
1098 |
3.134e-06 |
3.191e-05 |
458 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
16 |
30 |
3.235e-06 |
3.28e-05 |
459 |
REGULATION OF HEART RATE BY CARDIAC CONDUCTION |
16 |
30 |
3.235e-06 |
3.28e-05 |
460 |
EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS |
14 |
24 |
3.266e-06 |
3.289e-05 |
461 |
FACE DEVELOPMENT |
22 |
50 |
3.265e-06 |
3.289e-05 |
462 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
156 |
684 |
3.261e-06 |
3.289e-05 |
463 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
66 |
236 |
3.304e-06 |
3.32e-05 |
464 |
REGULATION OF CATENIN IMPORT INTO NUCLEUS |
15 |
27 |
3.349e-06 |
3.359e-05 |
465 |
MEMBRANE DEPOLARIZATION |
25 |
61 |
3.472e-06 |
3.467e-05 |
466 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
25 |
61 |
3.472e-06 |
3.467e-05 |
467 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
140 |
602 |
3.513e-06 |
3.5e-05 |
468 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
31 |
84 |
3.544e-06 |
3.524e-05 |
469 |
REGULATION OF CATION CHANNEL ACTIVITY |
32 |
88 |
3.587e-06 |
3.558e-05 |
470 |
METAL ION TRANSPORT |
136 |
582 |
3.704e-06 |
3.667e-05 |
471 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
11 |
16 |
3.942e-06 |
3.895e-05 |
472 |
CELLULAR HOMEOSTASIS |
154 |
676 |
4.027e-06 |
3.97e-05 |
473 |
RESPONSE TO OXIDATIVE STRESS |
90 |
352 |
4.087e-06 |
4.02e-05 |
474 |
REGULATION OF STEM CELL DIFFERENTIATION |
38 |
113 |
4.13e-06 |
4.054e-05 |
475 |
REGULATION OF MEMBRANE LIPID DISTRIBUTION |
18 |
37 |
4.427e-06 |
4.328e-05 |
476 |
CARDIAC MUSCLE CELL ACTION POTENTIAL |
18 |
37 |
4.427e-06 |
4.328e-05 |
477 |
OSTEOBLAST DIFFERENTIATION |
41 |
126 |
4.5e-06 |
4.38e-05 |
478 |
PROTEIN AUTOPHOSPHORYLATION |
56 |
192 |
4.498e-06 |
4.38e-05 |
479 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
47 |
152 |
4.596e-06 |
4.465e-05 |
480 |
GLYCOPROTEIN METABOLIC PROCESS |
90 |
353 |
4.625e-06 |
4.484e-05 |
481 |
SEGMENTATION |
32 |
89 |
4.736e-06 |
4.581e-05 |
482 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
17 |
34 |
5.081e-06 |
4.905e-05 |
483 |
MESODERM MORPHOGENESIS |
26 |
66 |
5.343e-06 |
5.126e-05 |
484 |
REGULATION OF CARDIAC CONDUCTION |
26 |
66 |
5.343e-06 |
5.126e-05 |
485 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
26 |
66 |
5.343e-06 |
5.126e-05 |
486 |
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION |
52 |
175 |
5.397e-06 |
5.167e-05 |
487 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
61 |
216 |
5.442e-06 |
5.2e-05 |
488 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
27 |
70 |
5.678e-06 |
5.414e-05 |
489 |
CELLULAR LIPID METABOLIC PROCESS |
198 |
913 |
5.79e-06 |
5.51e-05 |
490 |
MYELOID CELL DIFFERENTIATION |
55 |
189 |
5.871e-06 |
5.575e-05 |
491 |
REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
15 |
28 |
6.131e-06 |
5.798e-05 |
492 |
MUSCLE HYPERTROPHY |
15 |
28 |
6.131e-06 |
5.798e-05 |
493 |
KIDNEY MORPHOGENESIS |
30 |
82 |
6.207e-06 |
5.847e-05 |
494 |
CARDIAC CONDUCTION |
30 |
82 |
6.207e-06 |
5.847e-05 |
495 |
RESPONSE TO CORTICOSTEROID |
52 |
176 |
6.467e-06 |
6.079e-05 |
496 |
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
10 |
14 |
6.591e-06 |
6.183e-05 |
497 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
133 |
573 |
6.779e-06 |
6.337e-05 |
498 |
NEGATIVE REGULATION OF GROWTH |
65 |
236 |
6.783e-06 |
6.337e-05 |
499 |
RESPONSE TO DRUG |
105 |
431 |
7.079e-06 |
6.601e-05 |
500 |
SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
18 |
38 |
7.139e-06 |
6.643e-05 |
501 |
RESPONSE TO ESTROGEN |
61 |
218 |
7.486e-06 |
6.939e-05 |
502 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
61 |
218 |
7.486e-06 |
6.939e-05 |
503 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
64 |
232 |
7.518e-06 |
6.954e-05 |
504 |
SPROUTING ANGIOGENESIS |
20 |
45 |
7.532e-06 |
6.954e-05 |
505 |
POSITIVE REGULATION OF CHEMOTAXIS |
39 |
120 |
7.863e-06 |
7.245e-05 |
506 |
CALCIUM ION TRANSPORT |
62 |
223 |
7.911e-06 |
7.275e-05 |
507 |
ARTERY DEVELOPMENT |
28 |
75 |
8.011e-06 |
7.309e-05 |
508 |
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
28 |
75 |
8.011e-06 |
7.309e-05 |
509 |
ODONTOGENESIS OF DENTIN CONTAINING TOOTH |
28 |
75 |
8.011e-06 |
7.309e-05 |
510 |
POSITIVE REGULATION OF AUTOPHAGY |
28 |
75 |
8.011e-06 |
7.309e-05 |
511 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
23 |
56 |
8.111e-06 |
7.385e-05 |
512 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
87 |
343 |
8.214e-06 |
7.465e-05 |
513 |
GASTRULATION |
47 |
155 |
8.254e-06 |
7.487e-05 |
514 |
CELLULAR CHEMICAL HOMEOSTASIS |
132 |
570 |
8.278e-06 |
7.493e-05 |
515 |
EAR MORPHOGENESIS |
37 |
112 |
8.741e-06 |
7.898e-05 |
516 |
CATION TRANSPORT |
175 |
796 |
8.821e-06 |
7.954e-05 |
517 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
24 |
60 |
8.937e-06 |
8.043e-05 |
518 |
CARDIAC SEPTUM MORPHOGENESIS |
21 |
49 |
9.015e-06 |
8.097e-05 |
519 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
40 |
125 |
9.219e-06 |
8.265e-05 |
520 |
DENDRITE MORPHOGENESIS |
19 |
42 |
9.256e-06 |
8.282e-05 |
521 |
POSITIVE REGULATION OF PROTEIN IMPORT |
35 |
104 |
9.561e-06 |
8.539e-05 |
522 |
PEPTIDYL TYROSINE DEPHOSPHORYLATION |
34 |
100 |
9.927e-06 |
8.849e-05 |
523 |
REGULATION OF CELL JUNCTION ASSEMBLY |
26 |
68 |
1.013e-05 |
9.016e-05 |
524 |
CYTOSOLIC CALCIUM ION TRANSPORT |
22 |
53 |
1.036e-05 |
9.198e-05 |
525 |
POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS |
9 |
12 |
1.054e-05 |
9.309e-05 |
526 |
EMBRYONIC CAMERA TYPE EYE FORMATION |
9 |
12 |
1.054e-05 |
9.309e-05 |
527 |
INNER EAR MORPHOGENESIS |
32 |
92 |
1.052e-05 |
9.309e-05 |
528 |
OVULATION CYCLE PROCESS |
31 |
88 |
1.071e-05 |
9.44e-05 |
529 |
REGULATION OF CALCIUM MEDIATED SIGNALING |
28 |
76 |
1.074e-05 |
9.443e-05 |
530 |
CARDIAC MUSCLE CELL CONTRACTION |
15 |
29 |
1.08e-05 |
9.477e-05 |
531 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
97 |
395 |
1.1e-05 |
9.64e-05 |
532 |
NEGATIVE REGULATION OF CELL GROWTH |
50 |
170 |
1.107e-05 |
9.68e-05 |
533 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
18 |
39 |
1.125e-05 |
9.793e-05 |
534 |
REGULATION OF AXON GUIDANCE |
18 |
39 |
1.125e-05 |
9.793e-05 |
535 |
PEPTIDYL THREONINE MODIFICATION |
20 |
46 |
1.13e-05 |
9.793e-05 |
536 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
20 |
46 |
1.13e-05 |
9.793e-05 |
537 |
MELANOCYTE DIFFERENTIATION |
12 |
20 |
1.129e-05 |
9.793e-05 |
538 |
CYCLIC NUCLEOTIDE METABOLIC PROCESS |
23 |
57 |
1.152e-05 |
9.965e-05 |
539 |
REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING |
13 |
23 |
1.19e-05 |
0.0001027 |
540 |
HOMEOSTASIS OF NUMBER OF CELLS |
51 |
175 |
1.204e-05 |
0.0001038 |
541 |
POSITIVE REGULATION OF CELL ADHESION |
93 |
376 |
1.22e-05 |
0.000105 |
542 |
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION |
57 |
203 |
1.311e-05 |
0.0001125 |
543 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
21 |
50 |
1.318e-05 |
0.0001129 |
544 |
ESTABLISHMENT OF PROTEIN LOCALIZATION |
289 |
1423 |
1.353e-05 |
0.0001157 |
545 |
POSITIVE REGULATION OF ION TRANSPORT |
64 |
236 |
1.364e-05 |
0.0001165 |
546 |
CEREBRAL CORTEX CELL MIGRATION |
19 |
43 |
1.407e-05 |
0.0001199 |
547 |
REGULATION OF PLASMA MEMBRANE ORGANIZATION |
27 |
73 |
1.411e-05 |
0.0001201 |
548 |
FORMATION OF PRIMARY GERM LAYER |
36 |
110 |
1.454e-05 |
0.0001234 |
549 |
MEMBRANE ORGANIZATION |
193 |
899 |
1.458e-05 |
0.0001235 |
550 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
60 |
218 |
1.538e-05 |
0.0001301 |
551 |
NEGATIVE REGULATION OF MAPK CASCADE |
44 |
145 |
1.547e-05 |
0.0001307 |
552 |
CELL MATRIX ADHESION |
38 |
119 |
1.61e-05 |
0.0001357 |
553 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
33 |
98 |
1.675e-05 |
0.000141 |
554 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
37 |
115 |
1.714e-05 |
0.0001439 |
555 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
49 |
168 |
1.726e-05 |
0.0001447 |
556 |
MAMMARY GLAND MORPHOGENESIS |
18 |
40 |
1.737e-05 |
0.000145 |
557 |
NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
18 |
40 |
1.737e-05 |
0.000145 |
558 |
NEURAL TUBE FORMATION |
32 |
94 |
1.739e-05 |
0.000145 |
559 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
36 |
111 |
1.819e-05 |
0.0001514 |
560 |
PROTEIN CATABOLIC PROCESS |
132 |
579 |
1.861e-05 |
0.0001546 |
561 |
RESPONSE TO ESTRADIOL |
44 |
146 |
1.871e-05 |
0.0001549 |
562 |
ION TRANSMEMBRANE TRANSPORT |
178 |
822 |
1.87e-05 |
0.0001549 |
563 |
REGULATION OF DENDRITE MORPHOGENESIS |
27 |
74 |
1.882e-05 |
0.0001552 |
564 |
ACTIN MEDIATED CELL CONTRACTION |
27 |
74 |
1.882e-05 |
0.0001552 |
565 |
REGULATION OF CELL PROJECTION ASSEMBLY |
46 |
155 |
1.895e-05 |
0.000156 |
566 |
ANION TRANSPORT |
118 |
507 |
1.931e-05 |
0.0001587 |
567 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
41 |
133 |
1.965e-05 |
0.0001612 |
568 |
VACUOLAR TRANSPORT |
67 |
253 |
2.01e-05 |
0.0001646 |
569 |
REGULATION OF CALCIUM ION IMPORT |
34 |
103 |
2.027e-05 |
0.0001657 |
570 |
POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION |
14 |
27 |
2.056e-05 |
0.0001678 |
571 |
GLYCEROLIPID METABOLIC PROCESS |
88 |
356 |
2.116e-05 |
0.0001724 |
572 |
CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION |
17 |
37 |
2.121e-05 |
0.0001725 |
573 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
33 |
99 |
2.126e-05 |
0.0001725 |
574 |
CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT |
37 |
116 |
2.127e-05 |
0.0001725 |
575 |
CHONDROCYTE DEVELOPMENT |
12 |
21 |
2.244e-05 |
0.0001816 |
576 |
REGULATION OF MUSCLE CONTRACTION |
44 |
147 |
2.256e-05 |
0.0001823 |
577 |
PEPTIDYL AMINO ACID MODIFICATION |
181 |
841 |
2.308e-05 |
0.0001861 |
578 |
LEUKOCYTE MIGRATION |
68 |
259 |
2.366e-05 |
0.0001905 |
579 |
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT |
20 |
48 |
2.427e-05 |
0.000195 |
580 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
38 |
121 |
2.454e-05 |
0.0001969 |
581 |
RESPONSE TO CYTOKINE |
157 |
714 |
2.506e-05 |
0.0002007 |
582 |
CAMP METABOLIC PROCESS |
16 |
34 |
2.555e-05 |
0.0002042 |
583 |
LIPID METABOLIC PROCESS |
239 |
1158 |
2.582e-05 |
0.0002061 |
584 |
APOPTOTIC SIGNALING PATHWAY |
74 |
289 |
2.673e-05 |
0.000213 |
585 |
LIMBIC SYSTEM DEVELOPMENT |
33 |
100 |
2.684e-05 |
0.0002134 |
586 |
REGULATION OF DENDRITIC SPINE DEVELOPMENT |
22 |
56 |
2.923e-05 |
0.0002321 |
587 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
45 |
153 |
2.972e-05 |
0.0002351 |
588 |
MULTI MULTICELLULAR ORGANISM PROCESS |
58 |
213 |
2.967e-05 |
0.0002351 |
589 |
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
15 |
31 |
3.024e-05 |
0.0002389 |
590 |
REGULATION OF GLUCOSE IMPORT |
23 |
60 |
3.089e-05 |
0.0002432 |
591 |
CHONDROCYTE DIFFERENTIATION |
23 |
60 |
3.089e-05 |
0.0002432 |
592 |
GOLGI ORGANIZATION |
29 |
84 |
3.146e-05 |
0.0002473 |
593 |
INSULIN RECEPTOR SIGNALING PATHWAY |
28 |
80 |
3.221e-05 |
0.0002527 |
594 |
NEURAL TUBE DEVELOPMENT |
44 |
149 |
3.253e-05 |
0.0002545 |
595 |
REGULATION OF ACTION POTENTIAL |
17 |
38 |
3.259e-05 |
0.0002545 |
596 |
MESENCHYME MORPHOGENESIS |
17 |
38 |
3.259e-05 |
0.0002545 |
597 |
ENDOTHELIAL CELL DIFFERENTIATION |
26 |
72 |
3.286e-05 |
0.0002561 |
598 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
49 |
172 |
3.406e-05 |
0.000265 |
599 |
CARDIAC CELL DEVELOPMENT |
20 |
49 |
3.479e-05 |
0.0002702 |
600 |
VENTRICULAR SEPTUM MORPHOGENESIS |
14 |
28 |
3.498e-05 |
0.0002708 |
601 |
REGULATION OF FATTY ACID OXIDATION |
14 |
28 |
3.498e-05 |
0.0002708 |
602 |
REGULATION OF ERK1 AND ERK2 CASCADE |
63 |
238 |
3.547e-05 |
0.0002741 |
603 |
PROTEOLYSIS |
247 |
1208 |
3.662e-05 |
0.0002826 |
604 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
118 |
514 |
3.674e-05 |
0.000283 |
605 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
53 |
191 |
3.684e-05 |
0.0002834 |
606 |
NEPHRON EPITHELIUM DEVELOPMENT |
31 |
93 |
3.731e-05 |
0.0002864 |
607 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
21 |
53 |
3.796e-05 |
0.00029 |
608 |
NEURON PROJECTION EXTENSION |
21 |
53 |
3.796e-05 |
0.00029 |
609 |
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION |
21 |
53 |
3.796e-05 |
0.00029 |
610 |
MAINTENANCE OF CELL NUMBER |
40 |
132 |
3.82e-05 |
0.0002914 |
611 |
SYSTEM PROCESS |
350 |
1785 |
3.834e-05 |
0.0002919 |
612 |
REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
13 |
25 |
3.922e-05 |
0.0002972 |
613 |
GLYCEROPHOSPHOLIPID METABOLIC PROCESS |
75 |
297 |
3.915e-05 |
0.0002972 |
614 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM |
13 |
25 |
3.922e-05 |
0.0002972 |
615 |
REGULATION OF FAT CELL DIFFERENTIATION |
34 |
106 |
3.966e-05 |
0.0003001 |
616 |
CIRCADIAN REGULATION OF GENE EXPRESSION |
22 |
57 |
4.036e-05 |
0.0003049 |
617 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
190 |
898 |
4.135e-05 |
0.0003118 |
618 |
REGULATION OF PHOSPHATASE ACTIVITY |
39 |
128 |
4.146e-05 |
0.0003122 |
619 |
ACTIVIN RECEPTOR SIGNALING PATHWAY |
12 |
22 |
4.208e-05 |
0.0003163 |
620 |
REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL |
11 |
19 |
4.232e-05 |
0.0003176 |
621 |
REGULATION OF SODIUM ION TRANSPORT |
27 |
77 |
4.264e-05 |
0.0003195 |
622 |
CELLULAR RESPONSE TO ALCOHOL |
36 |
115 |
4.279e-05 |
0.0003201 |
623 |
PROTEIN LOCALIZATION TO VACUOLE |
19 |
46 |
4.463e-05 |
0.0003334 |
624 |
LIPID LOCALIZATION |
68 |
264 |
4.549e-05 |
0.0003392 |
625 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
70 |
274 |
4.699e-05 |
0.0003499 |
626 |
ACTIN FILAMENT ORGANIZATION |
49 |
174 |
4.719e-05 |
0.0003507 |
627 |
PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
185 |
873 |
4.75e-05 |
0.000352 |
628 |
REGULATION OF CELL CYCLE |
199 |
949 |
4.75e-05 |
0.000352 |
629 |
ENDOCARDIAL CUSHION DEVELOPMENT |
15 |
32 |
4.841e-05 |
0.0003581 |
630 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
17 |
39 |
4.908e-05 |
0.000362 |
631 |
COCHLEA DEVELOPMENT |
17 |
39 |
4.908e-05 |
0.000362 |
632 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
34 |
107 |
4.918e-05 |
0.0003621 |
633 |
REGULATION OF PROTEIN SECRETION |
93 |
389 |
4.957e-05 |
0.0003644 |
634 |
CARDIAC MUSCLE TISSUE MORPHOGENESIS |
21 |
54 |
5.268e-05 |
0.0003866 |
635 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
51 |
184 |
5.28e-05 |
0.0003869 |
636 |
VESICLE ORGANIZATION |
71 |
280 |
5.388e-05 |
0.0003942 |
637 |
RENAL TUBULE DEVELOPMENT |
27 |
78 |
5.522e-05 |
0.0004034 |
638 |
RAS PROTEIN SIGNAL TRANSDUCTION |
42 |
143 |
5.579e-05 |
0.0004062 |
639 |
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT |
42 |
143 |
5.579e-05 |
0.0004062 |
640 |
CELL CELL JUNCTION ASSEMBLY |
26 |
74 |
5.646e-05 |
0.0004105 |
641 |
SOMITOGENESIS |
23 |
62 |
5.664e-05 |
0.0004111 |
642 |
REGULATION OF POLYSACCHARIDE METABOLIC PROCESS |
18 |
43 |
5.704e-05 |
0.0004134 |
643 |
FOREBRAIN GENERATION OF NEURONS |
24 |
66 |
5.728e-05 |
0.0004145 |
644 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
31 |
95 |
5.917e-05 |
0.0004275 |
645 |
POSITIVE REGULATION OF CELL GROWTH |
43 |
148 |
6.062e-05 |
0.0004373 |
646 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY |
16 |
36 |
6.119e-05 |
0.0004407 |
647 |
DEPHOSPHORYLATION |
72 |
286 |
6.145e-05 |
0.0004419 |
648 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
56 |
209 |
6.545e-05 |
0.00047 |
649 |
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
13 |
26 |
6.681e-05 |
0.0004782 |
650 |
NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT |
13 |
26 |
6.681e-05 |
0.0004782 |
651 |
LOCOMOTORY BEHAVIOR |
50 |
181 |
6.829e-05 |
0.0004881 |
652 |
HORMONE MEDIATED SIGNALING PATHWAY |
45 |
158 |
7.018e-05 |
0.0004994 |
653 |
POSITIVE REGULATION OF FATTY ACID OXIDATION |
9 |
14 |
7.019e-05 |
0.0004994 |
654 |
RESPONSE TO PURINE CONTAINING COMPOUND |
45 |
158 |
7.018e-05 |
0.0004994 |
655 |
REGULATION OF STRIATED MUSCLE CONTRACTION |
27 |
79 |
7.106e-05 |
0.000504 |
656 |
ERBB SIGNALING PATHWAY |
27 |
79 |
7.106e-05 |
0.000504 |
657 |
EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
21 |
55 |
7.229e-05 |
0.0005112 |
658 |
REGULATION OF KIDNEY DEVELOPMENT |
21 |
55 |
7.229e-05 |
0.0005112 |
659 |
NEGATIVE REGULATION OF BINDING |
39 |
131 |
7.306e-05 |
0.0005158 |
660 |
REGULATION OF METANEPHROS DEVELOPMENT |
12 |
23 |
7.501e-05 |
0.000528 |
661 |
INNERVATION |
12 |
23 |
7.501e-05 |
0.000528 |
662 |
NEUROEPITHELIAL CELL DIFFERENTIATION |
23 |
63 |
7.562e-05 |
0.0005315 |
663 |
SYNAPTIC SIGNALING |
99 |
424 |
7.665e-05 |
0.0005379 |
664 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
36 |
118 |
7.801e-05 |
0.0005467 |
665 |
POSITIVE REGULATION OF BINDING |
38 |
127 |
7.974e-05 |
0.0005579 |
666 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
67 |
264 |
8.371e-05 |
0.0005849 |
667 |
REGULATION OF EMBRYONIC DEVELOPMENT |
35 |
114 |
8.453e-05 |
0.0005897 |
668 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
28 |
84 |
8.698e-05 |
0.000605 |
669 |
TISSUE MIGRATION |
28 |
84 |
8.698e-05 |
0.000605 |
670 |
POSITIVE REGULATION OF CELL DIVISION |
39 |
132 |
8.767e-05 |
0.0006089 |
671 |
POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
19 |
48 |
8.936e-05 |
0.0006197 |
672 |
AXON EXTENSION |
16 |
37 |
9.165e-05 |
0.0006346 |
673 |
NEGATIVE REGULATION OF CELL MATRIX ADHESION |
14 |
30 |
9.185e-05 |
0.000635 |
674 |
POSITIVE REGULATION OF TRANSPORTER ACTIVITY |
26 |
76 |
9.427e-05 |
0.0006508 |
675 |
CIRCADIAN RHYTHM |
40 |
137 |
9.56e-05 |
0.000659 |
676 |
REGULATION OF DNA BINDING |
30 |
93 |
9.802e-05 |
0.0006747 |
677 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT |
33 |
106 |
9.863e-05 |
0.0006769 |
678 |
FAT CELL DIFFERENTIATION |
33 |
106 |
9.863e-05 |
0.0006769 |
679 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
22 |
60 |
9.985e-05 |
0.0006842 |
680 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
90 |
381 |
0.0001028 |
0.0007034 |
681 |
REGULATION OF MEMBRANE DEPOLARIZATION |
17 |
41 |
0.0001053 |
0.0007194 |
682 |
NEGATIVE REGULATION OF AXON GUIDANCE |
13 |
27 |
0.0001098 |
0.0007477 |
683 |
AXIS ELONGATION |
13 |
27 |
0.0001098 |
0.0007477 |
684 |
HEMOSTASIS |
76 |
311 |
0.0001109 |
0.0007542 |
685 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
56 |
213 |
0.0001139 |
0.0007737 |
686 |
FOREBRAIN NEURON DEVELOPMENT |
15 |
34 |
0.0001149 |
0.0007787 |
687 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
38 |
129 |
0.000115 |
0.0007787 |
688 |
REGULATION OF JUN KINASE ACTIVITY |
27 |
81 |
0.0001154 |
0.0007807 |
689 |
EXOCRINE SYSTEM DEVELOPMENT |
18 |
45 |
0.0001161 |
0.0007826 |
690 |
ENDOCHONDRAL BONE MORPHOGENESIS |
18 |
45 |
0.0001161 |
0.0007826 |
691 |
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
26 |
77 |
0.0001206 |
0.0008121 |
692 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
70 |
282 |
0.0001226 |
0.0008241 |
693 |
RESPONSE TO FIBROBLAST GROWTH FACTOR |
35 |
116 |
0.0001245 |
0.0008362 |
694 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
39 |
134 |
0.0001251 |
0.0008377 |
695 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
25 |
73 |
0.0001251 |
0.0008377 |
696 |
REGULATION OF ODONTOGENESIS |
12 |
24 |
0.0001279 |
0.0008551 |
697 |
REGULATION OF CIRCADIAN RHYTHM |
32 |
103 |
0.0001303 |
0.0008688 |
698 |
STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
32 |
103 |
0.0001303 |
0.0008688 |
699 |
NEGATIVE REGULATION OF AXONOGENESIS |
23 |
65 |
0.0001313 |
0.0008743 |
700 |
EPIDERMIS DEVELOPMENT |
64 |
253 |
0.0001317 |
0.000875 |
701 |
MYOTUBE DIFFERENTIATION |
21 |
57 |
0.0001318 |
0.000875 |
702 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
16 |
38 |
0.0001346 |
0.0008897 |
703 |
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
16 |
38 |
0.0001346 |
0.0008897 |
704 |
POSITIVE REGULATION OF ORGAN GROWTH |
16 |
38 |
0.0001346 |
0.0008897 |
705 |
PIGMENTATION |
28 |
86 |
0.000138 |
0.0009105 |
706 |
EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
31 |
99 |
0.0001404 |
0.0009253 |
707 |
CELL AGGREGATION |
11 |
21 |
0.0001438 |
0.0009453 |
708 |
CARTILAGE CONDENSATION |
11 |
21 |
0.0001438 |
0.0009453 |
709 |
LIPID MODIFICATION |
55 |
210 |
0.0001453 |
0.0009536 |
710 |
NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
39 |
135 |
0.0001488 |
0.000975 |
711 |
OLFACTORY BULB INTERNEURON DIFFERENTIATION |
9 |
15 |
0.0001501 |
0.0009783 |
712 |
POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
9 |
15 |
0.0001501 |
0.0009783 |
713 |
BLASTODERM SEGMENTATION |
9 |
15 |
0.0001501 |
0.0009783 |
714 |
AUTONOMIC NERVOUS SYSTEM DEVELOPMENT |
17 |
42 |
0.0001503 |
0.0009783 |
715 |
REGULATION OF HEART GROWTH |
17 |
42 |
0.0001503 |
0.0009783 |
716 |
REGULATION OF WOUND HEALING |
37 |
126 |
0.0001507 |
0.0009795 |
717 |
AGING |
66 |
264 |
0.0001511 |
0.0009808 |
718 |
POSITIVE REGULATION OF SECRETION |
87 |
370 |
0.000157 |
0.001017 |
719 |
CELL CYCLE ARREST |
43 |
154 |
0.0001639 |
0.001058 |
720 |
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
38 |
131 |
0.0001637 |
0.001058 |
721 |
REGULATION OF SYNAPSE ORGANIZATION |
34 |
113 |
0.0001639 |
0.001058 |
722 |
NEURAL PRECURSOR CELL PROLIFERATION |
24 |
70 |
0.0001662 |
0.001071 |
723 |
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
19 |
50 |
0.0001697 |
0.001091 |
724 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
19 |
50 |
0.0001697 |
0.001091 |
725 |
SOMATIC STEM CELL POPULATION MAINTENANCE |
23 |
66 |
0.000171 |
0.001097 |
726 |
EMBRYONIC CAMERA TYPE EYE DEVELOPMENT |
15 |
35 |
0.0001711 |
0.001097 |
727 |
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION |
22 |
62 |
0.0001742 |
0.001115 |
728 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
52 |
197 |
0.000176 |
0.001125 |
729 |
GLIAL CELL DIFFERENTIATION |
39 |
136 |
0.0001764 |
0.001126 |
730 |
ANION TRANSMEMBRANE TRANSPORT |
63 |
251 |
0.0001871 |
0.001193 |
731 |
TRABECULA MORPHOGENESIS |
16 |
39 |
0.0001941 |
0.001235 |
732 |
POSITIVE REGULATION OF ENDOCYTOSIS |
34 |
114 |
0.0001977 |
0.001257 |
733 |
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
29 |
92 |
0.0001997 |
0.001268 |
734 |
EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS |
12 |
25 |
0.0002098 |
0.001326 |
735 |
MEMBRANE ASSEMBLY |
12 |
25 |
0.0002098 |
0.001326 |
736 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION |
12 |
25 |
0.0002098 |
0.001326 |
737 |
INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY |
24 |
71 |
0.0002128 |
0.001343 |
738 |
SECRETION |
128 |
588 |
0.000213 |
0.001343 |
739 |
REGULATION OF LIPID METABOLIC PROCESS |
69 |
282 |
0.000215 |
0.001353 |
740 |
REGULATION OF ORGAN FORMATION |
14 |
32 |
0.0002158 |
0.001355 |
741 |
ADIPOSE TISSUE DEVELOPMENT |
14 |
32 |
0.0002158 |
0.001355 |
742 |
GLIOGENESIS |
47 |
175 |
0.0002284 |
0.001432 |
743 |
ARTERY MORPHOGENESIS |
19 |
51 |
0.0002297 |
0.001439 |
744 |
REGULATION OF HORMONE LEVELS |
107 |
478 |
0.000232 |
0.001451 |
745 |
PHOSPHOLIPID METABOLIC PROCESS |
85 |
364 |
0.0002364 |
0.001476 |
746 |
LYMPHOCYTE DIFFERENTIATION |
54 |
209 |
0.0002407 |
0.001501 |
747 |
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT |
26 |
80 |
0.0002431 |
0.001514 |
748 |
POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION |
11 |
22 |
0.0002456 |
0.001522 |
749 |
PROTEIN LOCALIZATION TO CELL SURFACE |
11 |
22 |
0.0002456 |
0.001522 |
750 |
SOMATIC STEM CELL DIVISION |
11 |
22 |
0.0002456 |
0.001522 |
751 |
CELLULAR RESPONSE TO INTERLEUKIN 6 |
11 |
22 |
0.0002456 |
0.001522 |
752 |
REGULATION OF CELL ACTIVATION |
108 |
484 |
0.0002467 |
0.001527 |
753 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
42 |
152 |
0.0002483 |
0.001535 |
754 |
POSITIVE REGULATION OF AXON EXTENSION |
15 |
36 |
0.0002496 |
0.00154 |
755 |
MULTICELLULAR ORGANISM GROWTH |
25 |
76 |
0.0002573 |
0.001585 |
756 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
40 |
143 |
0.000261 |
0.001606 |
757 |
NEGATIVE REGULATION OF SECRETION |
52 |
200 |
0.0002633 |
0.001618 |
758 |
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY |
28 |
89 |
0.0002646 |
0.001624 |
759 |
STEM CELL DIVISION |
13 |
29 |
0.0002696 |
0.001646 |
760 |
PIGMENT CELL DIFFERENTIATION |
13 |
29 |
0.0002696 |
0.001646 |
761 |
POSITIVE REGULATION OF CARTILAGE DEVELOPMENT |
13 |
29 |
0.0002696 |
0.001646 |
762 |
NEUROBLAST PROLIFERATION |
13 |
29 |
0.0002696 |
0.001646 |
763 |
CELL CHEMOTAXIS |
44 |
162 |
0.0002721 |
0.001655 |
764 |
PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
38 |
134 |
0.0002718 |
0.001655 |
765 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
44 |
162 |
0.0002721 |
0.001655 |
766 |
POSITIVE REGULATION OF CELL MATRIX ADHESION |
16 |
40 |
0.0002751 |
0.001669 |
767 |
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
16 |
40 |
0.0002751 |
0.001669 |
768 |
REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION |
10 |
19 |
0.0002767 |
0.001677 |
769 |
MEMORY |
30 |
98 |
0.0002779 |
0.001682 |
770 |
RELAXATION OF CARDIAC MUSCLE |
8 |
13 |
0.0002819 |
0.001699 |
771 |
REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING |
8 |
13 |
0.0002819 |
0.001699 |
772 |
MESENCHYMAL CELL PROLIFERATION |
8 |
13 |
0.0002819 |
0.001699 |
773 |
RESPONSE TO ORGANOPHOSPHORUS |
39 |
139 |
0.0002891 |
0.00174 |
774 |
CARDIAC MYOFIBRIL ASSEMBLY |
9 |
16 |
0.0002938 |
0.001764 |
775 |
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT |
9 |
16 |
0.0002938 |
0.001764 |
776 |
RESPONSE TO AXON INJURY |
18 |
48 |
0.0003032 |
0.001811 |
777 |
REGULATION OF DEPHOSPHORYLATION |
43 |
158 |
0.0003026 |
0.001811 |
778 |
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
18 |
48 |
0.0003032 |
0.001811 |
779 |
POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
18 |
48 |
0.0003032 |
0.001811 |
780 |
POSITIVE REGULATION OF REPRODUCTIVE PROCESS |
19 |
52 |
0.0003075 |
0.001834 |
781 |
REGULATION OF NUCLEAR DIVISION |
44 |
163 |
0.0003151 |
0.001877 |
782 |
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN |
76 |
321 |
0.0003165 |
0.001883 |
783 |
EMBRYONIC AXIS SPECIFICATION |
14 |
33 |
0.0003193 |
0.001895 |
784 |
NEGATIVE REGULATION OF JNK CASCADE |
14 |
33 |
0.0003193 |
0.001895 |
785 |
INORGANIC ION TRANSMEMBRANE TRANSPORT |
126 |
583 |
0.0003236 |
0.001918 |
786 |
REPLACEMENT OSSIFICATION |
12 |
26 |
0.0003323 |
0.001965 |
787 |
ENDOCHONDRAL OSSIFICATION |
12 |
26 |
0.0003323 |
0.001965 |
788 |
CALCIUM ION TRANSMEMBRANE TRANSPORT |
43 |
159 |
0.0003507 |
0.002071 |
789 |
ORGANELLE LOCALIZATION |
94 |
415 |
0.0003542 |
0.002089 |
790 |
POSITIVE REGULATION OF CATION CHANNEL ACTIVITY |
15 |
37 |
0.0003573 |
0.002102 |
791 |
REGULATION OF PROTEIN AUTOPHOSPHORYLATION |
15 |
37 |
0.0003573 |
0.002102 |
792 |
REGULATION OF PROTEIN TARGETING |
73 |
307 |
0.0003591 |
0.00211 |
793 |
GLYCOSYLATION |
65 |
267 |
0.0003734 |
0.002191 |
794 |
CALCIUM ION IMPORT |
22 |
65 |
0.0003766 |
0.002199 |
795 |
JNK CASCADE |
26 |
82 |
0.0003766 |
0.002199 |
796 |
REGULATION OF CHEMOKINE PRODUCTION |
22 |
65 |
0.0003766 |
0.002199 |
797 |
INTEGRIN MEDIATED SIGNALING PATHWAY |
26 |
82 |
0.0003766 |
0.002199 |
798 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
16 |
41 |
0.0003839 |
0.00223 |
799 |
REGULATION OF VACUOLE ORGANIZATION |
16 |
41 |
0.0003839 |
0.00223 |
800 |
ANDROGEN RECEPTOR SIGNALING PATHWAY |
16 |
41 |
0.0003839 |
0.00223 |
801 |
LUNG ALVEOLUS DEVELOPMENT |
16 |
41 |
0.0003839 |
0.00223 |
802 |
LUNG MORPHOGENESIS |
17 |
45 |
4e-04 |
0.002321 |
803 |
ENDOTHELIAL CELL MIGRATION |
20 |
57 |
0.0004012 |
0.002325 |
804 |
REGULATION OF DENDRITIC SPINE MORPHOGENESIS |
13 |
30 |
0.0004056 |
0.002347 |
805 |
MESONEPHRIC TUBULE MORPHOGENESIS |
19 |
53 |
0.0004072 |
0.002351 |
806 |
SKELETAL MUSCLE CELL DIFFERENTIATION |
19 |
53 |
0.0004072 |
0.002351 |
807 |
RESPONSE TO HYDROGEN PEROXIDE |
32 |
109 |
0.0004097 |
0.002362 |
808 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
24 |
74 |
0.0004293 |
0.002472 |
809 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
27 |
87 |
0.0004309 |
0.002479 |
810 |
T CELL DIFFERENTIATION |
35 |
123 |
0.0004328 |
0.002486 |
811 |
REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
29 |
96 |
0.0004457 |
0.002557 |
812 |
LYSOSOMAL TRANSPORT |
23 |
70 |
0.000455 |
0.002607 |
813 |
POSITIVE REGULATION OF SODIUM ION TRANSPORT |
14 |
34 |
0.0004623 |
0.002643 |
814 |
REGULATION OF AUTOPHAGOSOME ASSEMBLY |
14 |
34 |
0.0004623 |
0.002643 |
815 |
REGENERATION |
43 |
161 |
0.0004679 |
0.002671 |
816 |
REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION |
10 |
20 |
0.0004732 |
0.002692 |
817 |
REFLEX |
10 |
20 |
0.0004732 |
0.002692 |
818 |
RELAXATION OF MUSCLE |
10 |
20 |
0.0004732 |
0.002692 |
819 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
81 |
351 |
0.0004817 |
0.002737 |
820 |
ORGANIC HYDROXY COMPOUND METABOLIC PROCESS |
106 |
482 |
0.0004884 |
0.002771 |
821 |
PROTEIN O LINKED GLYCOSYLATION |
30 |
101 |
0.0004924 |
0.002791 |
822 |
NEGATIVE REGULATION OF AXON EXTENSION |
15 |
38 |
0.0005025 |
0.002838 |
823 |
REGULATION OF SMOOTHENED SIGNALING PATHWAY |
21 |
62 |
0.0005014 |
0.002838 |
824 |
REGULATION OF RENAL SYSTEM PROCESS |
15 |
38 |
0.0005025 |
0.002838 |
825 |
POSITIVE REGULATION OF HEART GROWTH |
12 |
27 |
0.0005103 |
0.002864 |
826 |
DEVELOPMENTAL INDUCTION |
12 |
27 |
0.0005103 |
0.002864 |
827 |
HIPPO SIGNALING |
12 |
27 |
0.0005103 |
0.002864 |
828 |
CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
12 |
27 |
0.0005103 |
0.002864 |
829 |
REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY |
12 |
27 |
0.0005103 |
0.002864 |
830 |
CELLULAR GLUCAN METABOLIC PROCESS |
20 |
58 |
0.00052 |
0.002911 |
831 |
GLUCAN METABOLIC PROCESS |
20 |
58 |
0.00052 |
0.002911 |
832 |
LEUKOCYTE CELL CELL ADHESION |
62 |
255 |
0.0005205 |
0.002911 |
833 |
CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL |
16 |
42 |
0.0005276 |
0.002919 |
834 |
REGULATION OF CYTOKINE PRODUCTION |
121 |
563 |
0.0005273 |
0.002919 |
835 |
REGULATION OF COAGULATION |
27 |
88 |
0.0005269 |
0.002919 |
836 |
REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL |
7 |
11 |
0.0005265 |
0.002919 |
837 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
16 |
42 |
0.0005276 |
0.002919 |
838 |
REGULATION OF CELLULAR CARBOHYDRATE CATABOLIC PROCESS |
16 |
42 |
0.0005276 |
0.002919 |
839 |
OLFACTORY BULB INTERNEURON DEVELOPMENT |
7 |
11 |
0.0005265 |
0.002919 |
840 |
REGULATION OF CARBOHYDRATE CATABOLIC PROCESS |
16 |
42 |
0.0005276 |
0.002919 |
841 |
CALCIUM ION IMPORT INTO CYTOSOL |
16 |
42 |
0.0005276 |
0.002919 |
842 |
REGULATION OF EXOCYTOSIS |
48 |
186 |
0.0005316 |
0.002937 |
843 |
REGULATION OF RECEPTOR BINDING |
9 |
17 |
0.0005345 |
0.002938 |
844 |
CYCLIC NUCLEOTIDE CATABOLIC PROCESS |
9 |
17 |
0.0005345 |
0.002938 |
845 |
REGULATION OF PROTEIN KINASE A SIGNALING |
9 |
17 |
0.0005345 |
0.002938 |
846 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
24 |
75 |
0.0005355 |
0.002938 |
847 |
REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
9 |
17 |
0.0005345 |
0.002938 |
848 |
MULTI ORGANISM BEHAVIOR |
24 |
75 |
0.0005355 |
0.002938 |
849 |
REGULATION OF GLUCOSE METABOLIC PROCESS |
31 |
106 |
0.000538 |
0.002949 |
850 |
POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
29 |
97 |
0.0005387 |
0.002949 |
851 |
REGULATION OF COENZYME METABOLIC PROCESS |
18 |
50 |
0.0005409 |
0.002951 |
852 |
REGULATION OF COFACTOR METABOLIC PROCESS |
18 |
50 |
0.0005409 |
0.002951 |
853 |
RHO PROTEIN SIGNAL TRANSDUCTION |
18 |
50 |
0.0005409 |
0.002951 |
854 |
REGULATION OF ORGANELLE ASSEMBLY |
40 |
148 |
0.0005602 |
0.003052 |
855 |
REGULATION OF GLOMERULUS DEVELOPMENT |
8 |
14 |
0.0005642 |
0.003063 |
856 |
CAMP CATABOLIC PROCESS |
8 |
14 |
0.0005642 |
0.003063 |
857 |
REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY |
8 |
14 |
0.0005642 |
0.003063 |
858 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
45 |
172 |
0.0005689 |
0.003085 |
859 |
INTERACTION WITH HOST |
37 |
134 |
0.0005705 |
0.00309 |
860 |
ENDODERM DEVELOPMENT |
23 |
71 |
0.000571 |
0.00309 |
861 |
TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
41 |
153 |
0.0005813 |
0.003141 |
862 |
NEGATIVE REGULATION OF CELL ACTIVATION |
42 |
158 |
0.0006008 |
0.003243 |
863 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
43 |
163 |
0.0006187 |
0.003336 |
864 |
POSITIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
11 |
24 |
0.0006339 |
0.00341 |
865 |
POSITIVE REGULATION OF ATP METABOLIC PROCESS |
11 |
24 |
0.0006339 |
0.00341 |
866 |
BONE REMODELING |
14 |
35 |
0.0006565 |
0.003527 |
867 |
SECRETION BY CELL |
106 |
486 |
0.0006637 |
0.003562 |
868 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
48 |
188 |
0.0006862 |
0.003678 |
869 |
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL |
19 |
55 |
0.0006929 |
0.003706 |
870 |
ACTIN CYTOSKELETON REORGANIZATION |
19 |
55 |
0.0006929 |
0.003706 |
871 |
ERBB2 SIGNALING PATHWAY |
15 |
39 |
0.0006953 |
0.003714 |
872 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
169 |
829 |
0.0007036 |
0.003755 |
873 |
ENERGY RESERVE METABOLIC PROCESS |
23 |
72 |
0.000712 |
0.003795 |
874 |
REGULATION OF BLOOD PRESSURE |
44 |
169 |
0.0007262 |
0.003866 |
875 |
NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT |
33 |
117 |
0.0007366 |
0.003913 |
876 |
ORGANIC ANION TRANSPORT |
87 |
387 |
0.0007365 |
0.003913 |
877 |
MAMMARY GLAND DUCT MORPHOGENESIS |
12 |
28 |
0.0007622 |
0.004044 |
878 |
AXIS SPECIFICATION |
27 |
90 |
0.0007765 |
0.004094 |
879 |
STRIATED MUSCLE CONTRACTION |
29 |
99 |
0.0007769 |
0.004094 |
880 |
MIDBRAIN DEVELOPMENT |
27 |
90 |
0.0007765 |
0.004094 |
881 |
SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT |
10 |
21 |
0.0007727 |
0.004094 |
882 |
REGULATION OF GLIOGENESIS |
27 |
90 |
0.0007765 |
0.004094 |
883 |
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
27 |
90 |
0.0007765 |
0.004094 |
884 |
NEGATIVE REGULATION OF TRANSPORTER ACTIVITY |
21 |
64 |
0.0008071 |
0.004248 |
885 |
RESPONSE TO CAMP |
30 |
104 |
0.0008411 |
0.004422 |
886 |
SALIVARY GLAND DEVELOPMENT |
13 |
32 |
0.0008552 |
0.004476 |
887 |
BLOOD VESSEL REMODELING |
13 |
32 |
0.0008552 |
0.004476 |
888 |
ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE |
13 |
32 |
0.0008552 |
0.004476 |
889 |
NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
13 |
32 |
0.0008552 |
0.004476 |
890 |
REGULATION OF NEUROTRANSMITTER LEVELS |
48 |
190 |
0.0008796 |
0.004598 |
891 |
NEGATIVE REGULATION OF MAP KINASE ACTIVITY |
23 |
73 |
0.0008822 |
0.004602 |
892 |
HIPPOCAMPUS DEVELOPMENT |
23 |
73 |
0.0008822 |
0.004602 |
893 |
REGULATION OF ACTIN FILAMENT LENGTH |
41 |
156 |
0.0008844 |
0.004608 |
894 |
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
50 |
200 |
0.000895 |
0.004658 |
895 |
NEUROMUSCULAR JUNCTION DEVELOPMENT |
14 |
36 |
0.0009154 |
0.004733 |
896 |
POSITIVE REGULATION OF MITOTIC CELL CYCLE |
34 |
123 |
0.0009134 |
0.004733 |
897 |
REGULATION OF NUCLEOTIDE CATABOLIC PROCESS |
14 |
36 |
0.0009154 |
0.004733 |
898 |
CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
14 |
36 |
0.0009154 |
0.004733 |
899 |
OLFACTORY LOBE DEVELOPMENT |
14 |
36 |
0.0009154 |
0.004733 |
900 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
14 |
36 |
0.0009154 |
0.004733 |
901 |
REGULATION OF GLUCOSE TRANSPORT |
29 |
100 |
0.0009273 |
0.004789 |
902 |
PLATELET ACTIVATION |
38 |
142 |
0.0009296 |
0.004796 |
903 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
17 |
48 |
0.000947 |
0.004855 |
904 |
REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS |
44 |
171 |
0.0009436 |
0.004855 |
905 |
FORELIMB MORPHOGENESIS |
15 |
40 |
0.0009473 |
0.004855 |
906 |
REGULATION OF RESPONSE TO NUTRIENT LEVELS |
44 |
171 |
0.0009436 |
0.004855 |
907 |
MYOFIBRIL ASSEMBLY |
17 |
48 |
0.000947 |
0.004855 |
908 |
DEVELOPMENTAL PIGMENTATION |
15 |
40 |
0.0009473 |
0.004855 |
909 |
HEPATICOBILIARY SYSTEM DEVELOPMENT |
35 |
128 |
0.0009577 |
0.004892 |
910 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
35 |
128 |
0.0009577 |
0.004892 |
911 |
ENDOCRINE PROCESS |
16 |
44 |
0.0009562 |
0.004892 |
912 |
LENS FIBER CELL DIFFERENTIATION |
11 |
25 |
0.0009671 |
0.004934 |
913 |
REGULATION OF IMMUNE SYSTEM PROCESS |
270 |
1403 |
0.0009832 |
0.005011 |
914 |
REGULATION OF CELL CELL ADHESION |
85 |
380 |
0.0009862 |
0.005021 |
915 |
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
21 |
65 |
0.001013 |
0.005149 |
916 |
MYELOID LEUKOCYTE DIFFERENTIATION |
28 |
96 |
0.001021 |
0.005187 |
917 |
REGULATION OF FATTY ACID METABOLIC PROCESS |
26 |
87 |
0.001025 |
0.005202 |
918 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
42 |
162 |
0.001035 |
0.005246 |
919 |
RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION |
8 |
15 |
0.001037 |
0.005252 |
920 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
82 |
365 |
0.001048 |
0.005301 |
921 |
MULTICELLULAR ORGANISMAL HOMEOSTASIS |
64 |
272 |
0.001063 |
0.005368 |
922 |
EMBRYONIC DIGIT MORPHOGENESIS |
20 |
61 |
0.001076 |
0.005431 |
923 |
NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT |
7 |
12 |
0.001087 |
0.005442 |
924 |
KERATINOCYTE PROLIFERATION |
7 |
12 |
0.001087 |
0.005442 |
925 |
NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE |
7 |
12 |
0.001087 |
0.005442 |
926 |
CARTILAGE MORPHOGENESIS |
7 |
12 |
0.001087 |
0.005442 |
927 |
AXON EXTENSION INVOLVED IN AXON GUIDANCE |
7 |
12 |
0.001087 |
0.005442 |
928 |
MECHANOSENSORY BEHAVIOR |
7 |
12 |
0.001087 |
0.005442 |
929 |
MAMMARY GLAND EPITHELIAL CELL PROLIFERATION |
7 |
12 |
0.001087 |
0.005442 |
930 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
12 |
29 |
0.00111 |
0.005547 |
931 |
REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC |
12 |
29 |
0.00111 |
0.005547 |
932 |
TUBE FORMATION |
35 |
129 |
0.001113 |
0.005556 |
933 |
EMBRYONIC PLACENTA DEVELOPMENT |
25 |
83 |
0.001121 |
0.005589 |
934 |
GOLGI VESICLE TRANSPORT |
73 |
319 |
0.001133 |
0.005645 |
935 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
18 |
53 |
0.00119 |
0.005922 |
936 |
NEURON RECOGNITION |
13 |
33 |
0.001204 |
0.005958 |
937 |
REGULATION OF PROTEIN BINDING |
43 |
168 |
0.001199 |
0.005958 |
938 |
EMBRYONIC DIGESTIVE TRACT DEVELOPMENT |
13 |
33 |
0.001204 |
0.005958 |
939 |
PROTEIN LOCALIZATION TO GOLGI APPARATUS |
13 |
33 |
0.001204 |
0.005958 |
940 |
POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS |
13 |
33 |
0.001204 |
0.005958 |
941 |
CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION |
10 |
22 |
0.001212 |
0.005992 |
942 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
24 |
79 |
0.001222 |
0.006032 |
943 |
REGULATION OF SYNAPSE ASSEMBLY |
24 |
79 |
0.001222 |
0.006032 |
944 |
MYELOID CELL HOMEOSTASIS |
26 |
88 |
0.001234 |
0.006065 |
945 |
RESPONSE TO EXTRACELLULAR STIMULUS |
96 |
441 |
0.001234 |
0.006065 |
946 |
POSITIVE REGULATION OF CHEMOKINE PRODUCTION |
17 |
49 |
0.001234 |
0.006065 |
947 |
CELLULAR RESPONSE TO CALCIUM ION |
17 |
49 |
0.001234 |
0.006065 |
948 |
NEGATIVE REGULATION OF GLIOGENESIS |
14 |
37 |
0.001255 |
0.006129 |
949 |
HINDLIMB MORPHOGENESIS |
14 |
37 |
0.001255 |
0.006129 |
950 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY |
14 |
37 |
0.001255 |
0.006129 |
951 |
REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
56 |
233 |
0.001255 |
0.006129 |
952 |
REGULATION OF MUSCLE HYPERTROPHY |
14 |
37 |
0.001255 |
0.006129 |
953 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
14 |
37 |
0.001255 |
0.006129 |
954 |
VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT |
16 |
45 |
0.001263 |
0.006154 |
955 |
POSITIVE REGULATION OF RECEPTOR ACTIVITY |
16 |
45 |
0.001263 |
0.006154 |
956 |
POSITIVE REGULATION OF KIDNEY DEVELOPMENT |
15 |
41 |
0.001272 |
0.006167 |
957 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
15 |
41 |
0.001272 |
0.006167 |
958 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
15 |
41 |
0.001272 |
0.006167 |
959 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
15 |
41 |
0.001272 |
0.006167 |
960 |
PROSTATE GLAND DEVELOPMENT |
15 |
41 |
0.001272 |
0.006167 |
961 |
NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS |
29 |
102 |
0.001306 |
0.006322 |
962 |
ADULT BEHAVIOR |
36 |
135 |
0.001335 |
0.006456 |
963 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
27 |
93 |
0.001342 |
0.006485 |
964 |
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE |
25 |
84 |
0.001354 |
0.006513 |
965 |
CARDIAC VENTRICLE MORPHOGENESIS |
20 |
62 |
0.00135 |
0.006513 |
966 |
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
25 |
84 |
0.001354 |
0.006513 |
967 |
CYTOKINESIS |
25 |
84 |
0.001354 |
0.006513 |
968 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
81 |
363 |
0.001375 |
0.006607 |
969 |
POSITIVE REGULATION OF CELL CYCLE |
75 |
332 |
0.001425 |
0.006842 |
970 |
NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT |
11 |
26 |
0.001433 |
0.006858 |
971 |
RESPONSE TO INTERLEUKIN 6 |
11 |
26 |
0.001433 |
0.006858 |
972 |
REGULATION OF CELL FATE COMMITMENT |
11 |
26 |
0.001433 |
0.006858 |
973 |
PHOSPHOLIPID TRANSPORT |
19 |
58 |
0.001437 |
0.006863 |
974 |
O GLYCAN PROCESSING |
19 |
58 |
0.001437 |
0.006863 |
975 |
INTRACELLULAR PROTEIN TRANSPORT |
158 |
781 |
0.001444 |
0.006891 |
976 |
POLYSACCHARIDE METABOLIC PROCESS |
24 |
80 |
0.001482 |
0.007065 |
977 |
LENS MORPHOGENESIS IN CAMERA TYPE EYE |
9 |
19 |
0.001491 |
0.007085 |
978 |
RETINA DEVELOPMENT IN CAMERA TYPE EYE |
35 |
131 |
0.00149 |
0.007085 |
979 |
POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION |
9 |
19 |
0.001491 |
0.007085 |
980 |
TRANSMISSION OF NERVE IMPULSE |
18 |
54 |
0.001518 |
0.007208 |
981 |
MEMBRANE BIOGENESIS |
12 |
30 |
0.001579 |
0.007491 |
982 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
82 |
370 |
0.001584 |
0.007505 |
983 |
CELLULAR RESPONSE TO CAMP |
17 |
50 |
0.001591 |
0.007529 |
984 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
33 |
122 |
0.001603 |
0.007581 |
985 |
GLIAL CELL DEVELOPMENT |
23 |
76 |
0.001619 |
0.007649 |
986 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
25 |
85 |
0.001627 |
0.007678 |
987 |
NEGATIVE REGULATION OF DNA BINDING |
16 |
46 |
0.001649 |
0.007766 |
988 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND |
16 |
46 |
0.001649 |
0.007766 |
989 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
80 |
360 |
0.001655 |
0.007786 |
990 |
RENAL WATER HOMEOSTASIS |
13 |
34 |
0.001662 |
0.007814 |
991 |
CELLULAR RESPONSE TO INORGANIC SUBSTANCE |
40 |
156 |
0.001679 |
0.007884 |
992 |
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
15 |
42 |
0.001686 |
0.007893 |
993 |
ENDOSOME TO LYSOSOME TRANSPORT |
15 |
42 |
0.001686 |
0.007893 |
994 |
POSITIVE REGULATION OF GLUCOSE TRANSPORT |
15 |
42 |
0.001686 |
0.007893 |
995 |
ENDOPLASMIC RETICULUM ORGANIZATION |
14 |
38 |
0.001694 |
0.007923 |
996 |
RESPONSE TO TOXIC SUBSTANCE |
57 |
241 |
0.001699 |
0.007937 |
997 |
MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION |
8 |
16 |
0.001781 |
0.008189 |
998 |
EXTRACELLULAR MATRIX ASSEMBLY |
8 |
16 |
0.001781 |
0.008189 |
999 |
MORPHOGENESIS OF AN ENDOTHELIUM |
8 |
16 |
0.001781 |
0.008189 |
1000 |
NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT |
8 |
16 |
0.001781 |
0.008189 |
1001 |
POSITIVE REGULATION OF PROTEIN SECRETION |
51 |
211 |
0.001769 |
0.008189 |
1002 |
ORGAN INDUCTION |
8 |
16 |
0.001781 |
0.008189 |
1003 |
NEURON CELL CELL ADHESION |
8 |
16 |
0.001781 |
0.008189 |
1004 |
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION |
8 |
16 |
0.001781 |
0.008189 |
1005 |
SMOOTHENED SIGNALING PATHWAY |
22 |
72 |
0.001765 |
0.008189 |
1006 |
PARAXIAL MESODERM DEVELOPMENT |
8 |
16 |
0.001781 |
0.008189 |
1007 |
MAGNESIUM ION TRANSMEMBRANE TRANSPORT |
8 |
16 |
0.001781 |
0.008189 |
1008 |
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
8 |
16 |
0.001781 |
0.008189 |
1009 |
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
8 |
16 |
0.001781 |
0.008189 |
1010 |
ACTIVATION OF MAPK ACTIVITY |
36 |
137 |
0.001765 |
0.008189 |
1011 |
BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS |
8 |
16 |
0.001781 |
0.008189 |
1012 |
REGULATION OF FATTY ACID BETA OXIDATION |
8 |
16 |
0.001781 |
0.008189 |
1013 |
REGULATION OF HORMONE SECRETION |
61 |
262 |
0.001792 |
0.00823 |
1014 |
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
19 |
59 |
0.001802 |
0.008267 |
1015 |
POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION |
10 |
23 |
0.001835 |
0.008395 |
1016 |
ESTABLISHMENT OF EPITHELIAL CELL POLARITY |
10 |
23 |
0.001835 |
0.008395 |
1017 |
ADRENAL GLAND DEVELOPMENT |
10 |
23 |
0.001835 |
0.008395 |
1018 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
82 |
372 |
0.001859 |
0.008496 |
1019 |
REGULATION OF NEUROLOGICAL SYSTEM PROCESS |
21 |
68 |
0.001918 |
0.00876 |
1020 |
POSITIVE REGULATION OF RESPONSE TO WOUNDING |
41 |
162 |
0.00193 |
0.008806 |
1021 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
25 |
86 |
0.001946 |
0.008867 |
1022 |
LIPID BIOSYNTHETIC PROCESS |
113 |
539 |
0.001947 |
0.008867 |
1023 |
DIENCEPHALON DEVELOPMENT |
23 |
77 |
0.00196 |
0.008917 |
1024 |
REGULATION OF VASCULOGENESIS |
7 |
13 |
0.002025 |
0.00915 |
1025 |
TYPE B PANCREATIC CELL DEVELOPMENT |
7 |
13 |
0.002025 |
0.00915 |
1026 |
MAGNESIUM ION TRANSPORT |
7 |
13 |
0.002025 |
0.00915 |
1027 |
PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
7 |
13 |
0.002025 |
0.00915 |
1028 |
EYELID DEVELOPMENT IN CAMERA TYPE EYE |
7 |
13 |
0.002025 |
0.00915 |
1029 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE |
7 |
13 |
0.002025 |
0.00915 |
1030 |
REGULATION OF CELL FATE SPECIFICATION |
7 |
13 |
0.002025 |
0.00915 |
1031 |
NEGATIVE REGULATION OF CHEMOTAXIS |
17 |
51 |
0.002031 |
0.009165 |
1032 |
REGULATION OF ASTROCYTE DIFFERENTIATION |
11 |
27 |
0.002067 |
0.009282 |
1033 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
11 |
27 |
0.002067 |
0.009282 |
1034 |
RESPONSE TO LITHIUM ION |
11 |
27 |
0.002067 |
0.009282 |
1035 |
SUBSTRATE DEPENDENT CELL MIGRATION |
11 |
27 |
0.002067 |
0.009282 |
1036 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS |
11 |
27 |
0.002067 |
0.009282 |
1037 |
REGULATION OF NEUROTRANSMITTER TRANSPORT |
20 |
64 |
0.002078 |
0.009324 |
1038 |
PEPTIDYL SERINE MODIFICATION |
38 |
148 |
0.002103 |
0.009426 |
1039 |
INTRA GOLGI VESICLE MEDIATED TRANSPORT |
16 |
47 |
0.002129 |
0.009525 |
1040 |
NEURON DEATH |
16 |
47 |
0.002129 |
0.009525 |
1041 |
POSITIVE REGULATION OF PROTEIN BINDING |
22 |
73 |
0.002146 |
0.009573 |
1042 |
PANCREAS DEVELOPMENT |
22 |
73 |
0.002146 |
0.009573 |
1043 |
CELLULAR RESPONSE TO KETONE |
22 |
73 |
0.002146 |
0.009573 |
1044 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
41 |
163 |
0.002183 |
0.009728 |
1045 |
MITOTIC CYTOKINESIS |
12 |
31 |
0.002201 |
0.009781 |
1046 |
CARDIAC ATRIUM DEVELOPMENT |
12 |
31 |
0.002201 |
0.009781 |
1047 |
MULTIVESICULAR BODY ORGANIZATION |
12 |
31 |
0.002201 |
0.009781 |
1048 |
CRANIAL NERVE DEVELOPMENT |
15 |
43 |
0.002207 |
0.009797 |
1049 |
NEGATIVE REGULATION OF CATABOLIC PROCESS |
49 |
203 |
0.002212 |
0.009813 |
1050 |
REPRODUCTION |
248 |
1297 |
0.002219 |
0.009832 |
1051 |
DEVELOPMENTAL MATURATION |
47 |
193 |
0.002225 |
0.009851 |
1052 |
REGULATION OF MONOOXYGENASE ACTIVITY |
19 |
60 |
0.002242 |
0.009897 |
1053 |
ORGANELLE TRANSPORT ALONG MICROTUBULE |
19 |
60 |
0.002242 |
0.009897 |
1054 |
MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY |
19 |
60 |
0.002242 |
0.009897 |
1055 |
REGULATION OF GLYCOGEN METABOLIC PROCESS |
13 |
35 |
0.002257 |
0.009916 |
1056 |
MEMBRANE PROTEIN PROTEOLYSIS |
13 |
35 |
0.002257 |
0.009916 |
1057 |
RESPONSE TO MINERALOCORTICOID |
13 |
35 |
0.002257 |
0.009916 |
1058 |
SPLEEN DEVELOPMENT |
14 |
39 |
0.002254 |
0.009916 |
1059 |
CYTOSKELETON DEPENDENT CYTOKINESIS |
14 |
39 |
0.002254 |
0.009916 |